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Lung cancer is the second most commonly diagnosed cancer 
in both males and females and the leading cause of cancer-related 
death in the United States (1). Lung cancer affects some races 
more than others; blacks have higher incidence and mortality 
rates than do whites (2,3). This report presents the first analysis 
of lung cancer incidence among racial/ethnic groups by U.S. 
census region. CDC analyzed data collected by CDC’s National 
Program of Cancer Registries (NPCR) and the National Cancer 
Institute’s Surveillance, Epidemiology, and End Results (SEER) 
Program for the period 1998–2006. These combined data reflect 
new lung cancer cases representing approximately 80% of the 
U.S. population. During this study period, annual incidence per 
100,000 population was highest among blacks (76.1), followed 
by whites (69.7), American Indians/Alaska Natives (AI/ANs) 
(48.4), and Asian/Pacific Islanders (A/PIs) (38.4). Hispanics had 
lower lung cancer incidence (37.3) than non-Hispanics (71.9). 
Incidence varied greatly with age, peaking among persons aged 
70–79 years (426.7). The region with the highest incidence 
was the South (76.0); the lowest was the West (58.8). Among 
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Great American Smokeout — 
November 18, 2010
The Great American Smokeout (GASO), sponsored 
by the American Cancer Society, is an annual event that 
encourages smokers to quit for at least 1 day in the hope 
that this might challenge them to stop permanently (1). 
This year, GASO will be held on November 18.
Major changes have occurred since the first GASO in 
1977. In 1978, approximately 34% of adults smoked; by 
2009, nearly 21% smoked (2–4). Federal laws now pro-
hibit smoking on airlines, and 24 states and the District 
of Columbia have comprehensive smoking bans (3,4). 
The U.S. government also has added coverage of smok-
ing cessation treatments to health plans. As of October 1, 
2010, Medicaid programs are required to cover tobacco-
dependence treatments for pregnant women, and in 2011, 
cessation coverage will be provided to all federal employees, 
retirees, and their spouses and dependents. 
Despite progress, 46.6 million U.S. adults smoke, 40% 
of nonsmokers are exposed to secondhand smoke, and 
443,000 deaths each year are attributed to smoking and 
secondhand smoke (3–5). Additional information and sup-
port for quitting is available online (http://www.smokefree.
gov) or by telephone (800-QUIT-NOW [800-784-8669]; 
TTY 800-332-8615).
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years 1998–2006. Because of the 79.5% population 
coverage, cancer rates derived from these data are 
considered to approximate national incidence. Only 
cancer cases with the primary site of lung or bron-
chus, according to the World Health Organization’s 
International Classification of Diseases for Oncology, 
Third Edition, were included in this analysis. Incidence 
is presented as average annual number of new cases 
per 100,000 persons. All findings are statistically 
significant unless otherwise noted. With the excep-
tion of age-specific rates, rates are age-adjusted to the 
2000 U.S. standard population with 19 age groups.† 
Adjustments to population data were made by the 
U.S. Census Bureau to account for the Gulf Coast 
population in Alabama, Mississippi, Louisiana, and 
Texas displaced by Hurricanes Katrina and Rita in 
2005.§
During 1998–2006, a total of 1,433,172 persons 
received lung cancer diagnoses (annual incidence: 
69.3 per 100,000) in the United States (Table 1). 
Annual incidence per 100,000 was higher among 
whites, the highest lung cancer incidence was in the 
South (76.3); the highest incidence among blacks 
(88.9), AI/ANs (64.2), and Hispanics (40.6) were in 
the Midwest, and the highest incidence among A/PIs 
was in the West (42.5). These findings identify the 
racial/ethnic populations and geographic regions that 
would most benefit from enhanced efforts in primary 
prevention, specifically by reducing tobacco use and 
exposure to environmental carcinogens.
Data available from population-based cancer 
registries affiliated with NPCR, the SEER Program, 
or both were used in this analysis; new cases of can-
cer were those reported in NPCR as of January 31, 
2009, and in SEER as of November 1, 2008. Data 
were evaluated according to United States Cancer 
Statistics (USCS) eligibility criteria.* Thirty-eight 
states and the District of Columbia met these criteria, 
representing 79.5% of the U.S. population for the 
* The USCS dataset is the combined incidence data from CDC and 
the National Cancer Institute. USCS data provide the official federal 
statistics on cancer incidence from registries that have high-quality 
data for each year during the 1998–2006 period; 38 states and the 
District of Columbia met the data-quality standards. States that did 
not meet data-quality standards were Alabama, Arkansas, Arizona, 
Georgia, Maryland, Mississippi, New Hampshire, North Carolina, 
South Dakota, Tennessee, Virginia, and Wisconsin.
† Additional information available at http://seer.cancer.gov/popdata/
index.html.
§ Additional information available at http://www.census.gov/popest/
topics/methodology.
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males (88.2) than females (55.4). Incidence was high-
est among blacks (76.1), followed by whites (69.7), 
AI/ANs (48.4), and A/PIs (38.4). Hispanics had lower 
lung cancer incidence (37.3) than non-Hispanics 
(71.9). By age group, incidence was highest among 
persons aged 70–79 years (426.7), followed by ≥80 
years (354.8), 60–69 years (258.0), 50–59 years 
(86.5), 40–49 years (21.8), and <40 years (0.9), a pat-
tern that persisted within racial and ethnic categories 
(Table 2). Lung cancer incidence was higher among 
blacks and whites than among AI/ANs or A/PIs for 
all age groups. When analyzed by U.S. census region,¶ 
lung cancer incidence was highest in the South (76.0), 
followed by the Midwest (73.0), Northeast (68.6), and 
West (58.8) (Figure). Among whites, the highest lung 
cancer incidence was in the South (76.3); incidence 
among blacks (88.9), AI/ANs (64.2 [not significant]), 
and Hispanics (40.6 [not significant]) was highest in 
the Midwest, and incidence among A/PIs was highest 
in the West (42.5).
Reported by
TL Fairley, PhD, E Tai, MD, JS Townsend, MS, 
SL Stewart, PhD, CB Steele, DO, Div of Cancer Prevention 
and Control, National Center for Chronic Disease Preven-
tion and Health Promotion; SP Davis, PhD, Office on 
Smoking and Health, National Center for Chronic Disease 
Prevention and Health Promotion; JM Underwood, PhD, 
EIS Officer, CDC.
Editorial Note
The findings in this report indicate lung cancer 
incidence during 1998–2006 was higher in the black 
population and in persons in the southern United 
States. However, variation also was observed in lung 
cancer incidence among racial/ethnic groups by U.S. 
census region. These findings are consistent with 
reports indicating a higher incidence among blacks 
compared with other racial groups (2) and reports 
showing geographic differences in lung cancer inci-
dence among AI/ANs (4). Racial/ethnic disparities 
in lung cancer incidence are associated with multiple 
factors, including differences in smoking preva-
lence,** metabolism of tobacco smoke products (6), 
TABLE 1. Lung cancer incidence,* by sex and selected demographic characteristics — United States, 1998–2006†
Total Males Females
Characteristic No. Rate (95% CI) No. Rate (95% CI) No. Rate (95% CI)
Total 1,433,172 69.3 (69.1–69.4) 792,057 88.2 (88.0–88.4) 641,115 55.4 (55.3–55.6)
Age group (yrs)
 <40 10,570 0.9 (0.9–0.9) 5,087 0.9 (0.8–0.9) 5,483 1.0 (0.9–1.0)
 40–49 68,349 21.8 (21.7–22.0) 35,752 23.1 (22.8–23.3) 32,597 20.7 (20.4–20.9)
 50–59 207,554 86.5 (86.1–86.9) 116,977 100.0 (99.4–100.5) 90,577 73.7 (73.2–74.1)
 60–69 395,283 258.0 (257.2–258.8) 225,200 312.4 (311.1–313.7) 170,083 209.6 (208.6–210.6)
 70–79 496,101 426.7 (425.5–427.9) 277,254 553.0 (551.0–555.1) 218,847 330.9 (329.6–332.3)
 ≥80 255,315 354.8 (353.4–356.2) 131,787 532.1 (529.2–535.0) 123,528 261.8 (260.3–263.2)
Race§
White 1,269,605 69.7 (69.6–69.8) 695,882 87.5 (87.3–87.7) 573,723 56.6 (56.5–56.8)
Black 124,407 76.1 (75.7–76.5) 73,413 110.2 (109.4–111.1) 50,994 53.3 (52.8–53.8)
American Indian/Alaska Native 5,769 48.4 (47.1–49.8) 3,039 58.3 (56.1–60.6) 2,730 41.2 (39.6–42.8)
Asian/Pacific Islander 27,787 38.4 (38.0–38.9) 16,548 53.0 (52.1–53.8) 11,239 27.5 (26.9–28.0)
Ethnicity
Non-Hispanic 1,378,181 71.9 (71.8–72.1) 852,058,465 91.2 (91.0–91.4) 618,608 57.8 (57.7–58.0)
Hispanic 54,990 37.3 (36.9–37.6) 159,589,451 51.7 (51.1–52.3) 22,507 26.8 (26.5–27.2)
Abbreviation: CI = confidence interval.
* Average annual rates of lung cancer diagnosed per 100,000 persons, age adjusted to the 2000 U.S. standard population.
† Data are from the population-based cancer registries covering 79.5% of the U.S. population. The United States Cancer Statistics (USCS) dataset is the combined incidence data from CDC and 
the National Cancer Institute. USCS data provide the official federal statistics on cancer incidence from registries that have high-quality data for each year from 1998 to 2006; 38 states and 
the District of Columbia met data-quality standards. States that did not meet data-quality standards included Alabama, Arkansas, Arizona, Georgia, Maryland, Mississippi, New Hampshire, 
North Carolina, South Dakota, Tennessee, Virginia, and Wisconsin.
§ All persons are of either Hispanic or non-Hispanic ethnicity. Hispanics might be of any race. Counts do not sum to total because rates for unknown race were not calculated.
¶ Northeast: Connecticut, Maine, Massachusetts, Rhode Island, 
Vermont, New Jersey, New York, and Pennsylvania; Midwest: 
Indiana, Illinois, Michigan, Ohio, Iowa, Nebraska, Kansas, North 
Dakota, Minnesota, and Missouri; South: Delaware, District of 
Columbia, Florida, South Carolina, West Virginia, Kentucky, 
Louisiana, Oklahoma, and Texas; West: Colorado, Idaho, New 
Mexico, Montana, Utah, Nevada, Wyoming, Alaska, California, 
Hawaii, Oregon, and Washington.
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susceptibility to tobacco-induced lung cancer (7), and 
socioeconomic status (8). Blacks are more susceptible 
to smoking-induced lung cancer (7) and have less 
access to health-care services compared with whites.†† 
These factors might contribute to the higher lung 
cancer incidence in the black population. Lung cancer 
also is caused by environmental exposures. Radon, for 
example, is a naturally occurring, colorless, odorless 
gas that can become trapped in buildings; it is the 
second leading cause of lung cancer overall, and the 
leading cause of lung cancer in nonsmokers.§§
This report presents an analysis of lung cancer 
incidence in all racial/ethnic groups by U.S. cen-
sus region. The observed variation in lung cancer 
incidence by region parallels a reported variation in 
smoking prevalence across the United States, includ-
ing higher smoking rates in the South and Midwest 
and lower rates in the West (9). Regional differences 
also were observed in smoking prevalence by race/
ethnicity, including a higher smoking prevalence 
among whites in the South, blacks and Hispanics 
in the Midwest, and A/PIs in the West (9). State 
 †† Additional information available at http://www.nap.edu/openbook.
php?record_id=12875&page=R1.
 §§ Additional information available at http://www.epa.gov/radon/
healthrisks.html.
TABLE 2. Lung cancer incidence,* by race/ethnicity and age group — United States, 1998–2006†
Total White§ Black§ American Indian/Alaska Native§
Characteristic No. Rate (95% CI) No. Rate (95% CI) No. Rate (95% CI) No. Rate (95% CI)
Total 1,433,172 69.3 (69.1–69.4) 1,269,605 69.7 (69.6–69.8) 124,407 76.1 (75.7–76.5) 5,769 48.4 (47.1–49.8)
Age group (yrs)
 <40 10,570 0.9 (0.9–0.9) 8,504 0.9 (0.9–0.9) 1,396 0.9 (0.9–1.0) 65 0.5 (0.4–0.6)
 40–49 68,349 21.8 (21.7–22.0) 55,128 21.1 (20.9–21.3) 10,766 32.9 (32.3–33.6) 368 12.1 (10.9–13.4)
 50–59 207,554 86.5 (86.1–86.9) 175,406 85.5 (85.1–85.9) 25,696 117.8 (116.4–119.3) 1,107 54.8 (51.6–58.1)
 60–69 395,283 258.0 (257.2–258.8) 347,374 261.4 (260.5–262.3) 37,246 286.2 (283.3–289.1) 1,825 174.2 (166.3–182.4)
 70–79 496,101 426.7 (425.5–427.9) 448,812 432.9 (431.6–434.2) 34,721 422.7 (418.3–427.2) 1,723 313.1 (298.5–328.2)
 ≥80 255,315 354.8 (353.4–356.2) 234,381 356.9 (355.5–358.4) 14,582 340.3 (334.8–345.9) 681 260.0 (240.8–280.2)
Asian/Pacific Islander§ Hispanic Non-Hispanic
Characteristic No. Rate (95% CI) No. Rate (95% CI) No. Rate (95% CI)
Total 27,787 38.4 (38–38.9) 54,990 37.3 (36.9–37.6) 1,378,181 71.9 (71.8–72.1)
Age group (yrs)
 <40 479 0.7 (0.7–0.8) 1,021 0.4 (0.4–0.5) 9,549 1.0 (1.0–1.0)
 40–49 1,709 10.9 (10.4–11.5) 3,510 9.2 (8.9–9.5) 64,839 23.6 (23.4–23.8)
 50–59 4,377 39.9 (38.7–41.1) 8,909 39.6 (38.8–40.4) 198,644 91.3 (90.9–91.7)
 60–69 7,329 117.1 (114.4–119.8) 15,272 121.2 (119.3–123.2) 380,011 270.2 (269.4–271.1)
 70–79 9,069 237.1 (232.2–242.0) 17,639 233.8 (230.3–237.3) 478,462 440.1 (438.9–441.3)
 ≥80 4,824 276.6 (268.9–284.5) 8,639 247.9 (242.7–253.2) 246,676 360.2 (358.8–361.7)
Abbreviations: CI = confidence interval.
* Average annual rates of lung cancer diagnosed per 100,000 persons, age adjusted to the 2000 U.S. standard population.
† Data are from the population-based cancer registries covering 79.5% of the U.S. population. The United States Cancer Statistics (USCS) dataset is the combined incidence data from CDC and 
the National Cancer Institute. USCS data provide the official federal statistics on cancer incidence from registries that have high-quality data for each year from 1998 to 2006; 38 states and 
the District of Columbia met data-quality standards. States that did not meet data-quality standards included Alabama, Arkansas, Arizona, Georgia, Maryland, Mississippi, New Hampshire, 
North Carolina, South Dakota, Tennessee, Virginia, and Wisconsin. 
§ All persons are of either Hispanic or non-Hispanic ethnicity. Hispanics might be of any race.
* Average annual rates of lung cancer diagnosed per 100,000 persons, age adjusted to the 
2000 U.S. standard population.
† Data are from the population-based cancer registries covering 79.5% of the U.S. population. 
The United States Cancer Statistics (USCS) dataset is the combined incidence data from CDC 
and the National Cancer Institute. USCS data provide the official federal statistics on cancer 
incidence from registries that have high-quality data for each year from 1998 to 2006; 38 
states and the District of Columbia met data-quality standards. States that did not meet 
data-quality standards included Alabama, Arkansas, Arizona, Georgia, Maryland, Mississippi, 
New Hampshire, North Carolina, South Dakota, Tennessee, Virginia, and Wisconsin. 
§ Difference is statistically significant (nonoverlapping 95% confidence intervals).
¶ All persons are of either Hispanic or non-Hispanic ethnicity. Hispanics might be of any race.
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comprehensive tobacco control programs, which aim 
to reduce smoking and tobacco use, can help reduce 
regional variation of lung cancer incidence.
The findings in this report are subject to at least 
four limitations. First, USCS data include only 80% 
of the entire U.S. population and therefore might 
not accurately represent the whole U.S. popula-
tion. National estimates of lung cancer incidence 
might be underreported because many of the states 
that did not meet data-quality standards¶¶ are in 
the South, the region with the highest smoking 
prevalence (9). Despite incomplete U.S. population 
coverage, combined data from the NPCR and SEER 
programs provide the best source of information on 
population-based cancer incidence for the nation, 
and the only source of information for states having 
only NPCR-funded cancer surveillance programs. 
Second, information about smoking status is not 
available in the cancer registry data. As more complete 
incidence data become available for all populations 
in the United States, researchers might be able to 
further describe patterns of cancer incidence that are 
specifically related to tobacco use. Third, racial/ethnic 
data in registries generally are of varying quality for 
AI/ANs and Hispanics (5). Finally, the distribution 
of lung cancer histologic types was not considered in 
this analysis. Although racial differences in histology 
have been shown in previous studies (3), unpublished 
analyses by CDC show little variation in lung cancer 
histology by region or race/ethnicity (CDC, unpub-
lished data, 2010).
Observed variations in lung cancer incidence 
among racial/ethnic groups likely are influenced by 
differences in smoking prevalence, exposure to car-
cinogens, and genetic susceptibility to lung cancer. 
Tobacco control efforts to prevent initiation and 
increase cessation have been effective in decreasing 
lung cancer incidence overall and in narrowing the 
race-based disparity among young adult smokers (i.e., 
those aged 20–39 years) (10). A recent CDC report 
indicates that smoking prevalence varies among racial/
ethnic groups, and is highest among persons living 
below the federal poverty level and those with low 
educational attainment.*** Use of the U.S. Public 
Health Service Guidelines for Treating Tobacco Use 
 ¶¶ Additional information available at http://www.cdc.gov/cancer/
npcr/uscs/2006/technical_notes/criteria.htm.
 *** Additional information available at http://www.cdc.gov/vitalsigns/ 
tobaccouse/smoking.
and Dependence††† is recommended for all persons 
who use tobacco across the racial/ethnic groups 
included in this report. Smoking cessation counseling 
interventions (e.g., quitlines) and medications have 
been found to be effective cessation interventions in 
these various populations. CDC also recommends a 
comprehensive approach to tobacco control, includ-
ing evidence-based tobacco prevention and cessation 
strategies.§§§ For example, given that disparities in 
cigarette use exist, targeted media campaigns should 
be implemented to reduce social inequalities in smok-
ing and lower the risk for cancer-related morbidity 
and mortality in minority populations. Enhanced 
smoke-free laws, and reduced radon exposure also will 
help decrease lung cancer disparities.¶¶¶ In addition 
to the implementation of population-based interven-
tions, continued surveillance of lung cancer incidence 
and smoking prevalence within subpopulations in the 
United States is warranted.****
What is already known on this topic?
Racial and ethnic disparities in lung cancer incidence 
and mortality exist in the United States; blacks have 
been shown to have higher rates of lung cancer inci-
dence and mortality than the general population, and 
Hispanics have had lower rates.
What is added by this report?
This report is the first comprehensive analysis of lung 
cancer incidence for racial/ethnic subpopulations by 
U.S. census region, and reveals lung cancer incidence 
is higher in the South; lung cancer incidence is high-
est for whites in the South, for blacks, Hispanics, and 
American Indians/Alaska Natives in the Midwest, and 
for Asians/Pacific Islanders in the West.
What are the implications for public health practice?
Antismoking initiatives and efforts to reduce expo-
sure to environmental carcinogens (e.g., radon and 
secondhand smoke) should be implemented to 
reduce the toll of lung cancer among all populations, 
especially targeting those at risk.
 ††† Available at http://www.surgeongeneral.gov/tobacco/treating_ 
tobacco_use.pdf.
 §§§ Additional information available at http://www.cdc.gov/tobacco/
stateandcommunity/best_practices/pdfs/2007/bestpractices_
complete.pdf.
 ¶¶¶ Additional information available at http://www.lungusa.org/
assets/documents/publications/lung-disease-data/ala-lung-
cancer-in-african.pdf.
 **** Additional information available at http://apps.nccd.cdc.gov/
uscs and http://www.cdc.gov/brfss.
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cooperation rate = 66.0%).† In 2007, data, includ-
ing complete information on ADHD and sex, were 
obtained for 73,123 children aged 4–17 years. Data 
were weighted to account for unequal probabilities of 
selection of households and children, nonresponse, 
and households without landline telephones, and to 
reflect the demographic distribution of noninstitu-
tionalized children in the United States.§
In both 2003 and 2007, parents were asked 
whether or not a doctor or other health-care provider 
had ever told them that their child had “attention 
deficit disorder or attention deficit hyperactive dis-
order, that is, ADD or ADHD.” In 2007, parents 
who reported an ADHD diagnosis (ever) also were 
asked whether the child currently had ADHD and to 
describe its severity (mild, moderate, or severe). The 
question about medication use in the 2003 survey 
differed from that in the 2007 survey. Current medica-
tion treatment for ADHD was asked about children 
who ever had ADHD in 2003 and about children with 
current ADHD in 2007. Estimates of parent-reported 
ADHD (ever and current) among children aged 4–17 
years, current medication use, and ADHD severity 
were calculated overall and by sociodemographic 
characteristics (Table 1) using 2007 data and NSCH 
survey weights. Rates of ADHD by sociodemographic 
characteristics using the 2003 survey data have been 
published (4) and were compared with 2007 data 
for the present analysis (Table 2). Estimated rates 
of children medicated for ADHD were calculated 
by dividing the weighted estimate of the number of 
children with current ADHD who were being medi-
cated for the disorder by the total weighted estimate 
of the number of children aged 4–17 years. Prevalence 
ratios and 95% confidence intervals were calculated to 
Attention-deficit/hyperactivity disorder (ADHD) 
is a neurobehavioral disorder that typically begins in 
childhood and often persists into adulthood. ADHD 
is characterized by developmentally inappropriate 
levels of inattention and hyperactivity resulting in 
functional impairment in academic, family, and 
social settings (1). ADHD is the most commonly 
diagnosed neurobehavioral disorder of childhood, 
with previous reports documenting increasing trends 
in prevalence during the past decade and increases 
in ADHD medication use (2,3). National estimates 
of the number of children reported by their parents 
to have ever been diagnosed with ADHD and the 
percentage of children with ADHD currently taking 
ADHD medications were published in 2005 using 
data from the 2003 National Survey of Children’s 
Health (NSCH) (4,5). This report describes results 
from the second administration of NSCH in 2007 
(6), which indicated that the percentage of children 
aged 4–17 years with a parent-reported ADHD 
diagnosis (ever) increased from 7.8% to 9.5% dur-
ing 2003–2007, representing a 21.8% increase in 
4 years. The findings in this report help to further 
characterize the substantial impact of ADHD on 
families.
The 2003 and 2007 NSCH were national, cross-
sectional, random-digit–dialed landline telephone 
surveys used to estimate the prevalence of health and 
well-being indicators among children aged <18 years 
in the United States (5,6).* One child was selected 
randomly from each household to be the focus of 
the parent or guardian interview. Information about 
the design and response rates of the 2003 NSCH 
have been published (5). The design of the 2003 and 
2007 surveys were similar. During April 2007–July 
2008, a total of 91,642 interviews were completed 
for the 2007 NSCH (overall response rate = 46.7%; 
Increasing Prevalence of Parent-Reported 
Attention-Deficit/Hyperactivity Disorder Among Children — 
United States, 2003 and 2007
* The 2003 and 2007 NSCH were directed by the Health Resources 
and Services Administration’s Maternal Child Health Bureau and 
conducted by CDC’s National Center for Health Statistics through 
the State and Local Area Integrated Telephone Survey. Additional 
information about NSCH is available at http://www.cdc.gov/nchs/
slaits/nsch.htm.
† The response rate represents the percentage of households that 
completed interviews among all eligible households, including 
those that were not successfully contacted. The cooperation rate 
is the percentage of households that completed interviews among 
all eligible households that were contacted. NSCH attempts 
to minimize nonresponse bias by incorporating nonresponse 
adjustments in the development of the sampling weights.
§ Demographic distributions were based on the 2007 American 
Community Survey of the U.S. Census Bureau.
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compare ADHD prevalence (ever diagnosed, current 
ADHD diagnosis, and currently taking medications 
for ADHD) of sociodemographic subgroups to refer-
ent subgroups (Table 1), and across the two surveys 
(ever diagnosed; Tables 2 and 3).
Prevalence of ADHD diagnosis (ever) was com-
pared between the two surveys using weighted logistic 
regression, predicting ADHD from survey year, while 
controlling for sociodemographics. Statistical inter-
actions of survey year by sociodemographics were 
tested. The average annual percentage difference was 
calculated by dividing the 2003 to 2007 percentage 
difference by 4.¶
In 2007, the estimated prevalence of parent-
reported ADHD (ever) among children aged 4–17 
years was 9.5%, representing 5.4 million children 
(Table 1). Of those with a history of ADHD, 78% 
(4.1 million, or 7.2% of all children aged 4–17 years) 
TABLE 1. Weighted prevalence estimates of parent-reported attention-deficit/hyperactivity disorder (ADHD) among chil-
dren aged 4–17 years,* by sociodemographic characteristics — National Survey of Children’s Health, United States, 2007




Current ADHD diagnosis 
and medicated for ADHD
Characteristic % (95% CI) PR % (95% CI) PR % (95% CI) PR
Overall 9.5 (9.0–10.0) NC 7.2 (6.8–7.7) NC 4.8 (4.4–5.1) NC
Sex
Male 13.2 (12.4–14.0) 2.33 10.3 (9.5–11.1) 2.57 6.9 (6.3–7.5) 2.76
Female 5.6 (5.1–6.3) Referent 4.0 (3.6,4.5) Referent 2.5 (2.2–2.8) Referent
Age group (yrs)    
 4–10 6.6 (6.1–7.3) Referent 5.5 (4.9,6.1) Referent 3.7 (3.3–4.1) Referent
 11–14 11.2 (10.3–12.2) 1.69 8.6 (7.8,9.5) 1.57 6.3 (5.6–7.0) 1.71
 15–17 13.6 (12.3–15.1) 2.05 9.3 (8.2,10.5) 1.70 5.2 (4.5–6.0) 1.42
Highest education in household
Less than high school 8.4 (7.0–10.0) 0.96† 6.5 (5.2–8.0) 0.96† 4.0 (3.0–5.2) 0.88†
High school graduate 12.2 (10.9–13.7) 1.40 9.0 (8.0–10.2) 1.34 5.9 (5.1–6.8) 1.31
More than high school 8.7 (8.2–9.3) Referent 6.7 (6.2–7.3) Referent 4.5 (4.1–4.9) Referent
Race 
White 9.9 (9.3–10.5) Referent 7.5 (7.0–8.0) Referent 5.1 (4.7–5.6) Referent
Black 10.1 (8.9–11.5) 1.02† 7.8 (6.7–9.1) 1.04† 5.1 (4.2–6.2) 0.99†
Multiracial 14.2 (11.5–17.4) 1.44 11.3 (8.9–14.1) 1.51 7.5 (5.6–10.0) 1.46
Other 5.0 (3.7–6.7) 0.51 3.7 (2.6–5.3) 0.50 1.7 (1.2–2.3) 0.33
Ethnicity
Hispanic/Latino 5.6 (4.6–7.0) 0.54 4.1 (3.3–5.2) 0.52 2.4 (1.7–3.2) 0.44
Non-Hispanic/Latino 10.5 (9.9–11.0) Referent 8.0 (7.5–8.5) Referent 5.4 (5.0–5.8) Referent
Primary language in home
English 10.5 (9.9–11.1) Referent 8.0 (7.5–8.5) Referent 5.3 (4.9–5.7) Referent
Any other language 2.3 (1.6–3.2) 0.22 1.8 (1.2–2.7) 0.23 0.9§ (0.5–1.6) 0.16
Poverty level¶
 ≤100% 11.6 (10.3–13.0) 1.35† 9.2 (8.1–10.5) 1.42† 6.3 (5.3–7.4) 1.45†
 >100% to ≤200% 10.3 (9.1–11.7) 1.20† 7.7 (6.6–8.9) 1.19† 4.7 (4.0–5.5) 1.08†
 >200% 8.6 (8.0–9.2) Referent 6.5 (6.0–7.0) Referent 4.4 (4.0–4.8) Referent
Any health-care coverage
Yes 9.8 (9.3–10.3)  7.6 (7.1–8.1)  5.1 (4.7–5.5)  
Medicaid 13.6 (12.5–14.8) 1.68 10.9 (9.8–12.0) 1.77 7.5 (6.7–8.4) 1.84
Non-Medicaid 8.1 (7.5–8.7) Referent 6.1 (5.6–6.7) Referent 4.1 (3.7–4.5) Referent
No 6.7 (5.2–8.6) 0.83† 3.7 (2.9–4.7) 0.60 1.7 (1.2–2.5) 0.42
Region
Northeast 9.4 (8.3–10.6) 1.35 7.4 (6.5–8.6) 1.45 4.5 (3.8–5.4) 1.60
Midwest 9.9 (9.2–10.7) 1.43 7.6 (6.9–8.3) 1.47 5.3 (4.7–5.8) 1.85
South 10.9 (10.1–11.8) 1.57 8.3 (7.6–9.0) 1.61 5.8 (5.2–6.5) 2.05
West 7.0 (5.7–8.4) Referent 5.1 (4.1–6.4) Referent 2.8 (2.2–3.7) Referent
Abbreviations: CI = confidence interval; NC = not calculated; PR = prevalence ratio (the ratio of the percentage of children with ADHD among 
the sociodemographic group to the percentage of children with ADHD among the referent sociodemographic group).
* Estimates do not include children aged 2–3 years with reported ADHD diagnosis because small sample size yields substantial (>30%) relative 
standard errors.
† PR is not significant at the α = 0.05 level.
§ Relative standard error >30%.
¶ Federal poverty level, imputed using multiple imputation for 8.9% of the sample for which reported household income was missing.
¶ The time between the two surveys was calculated from the survey 
midpoints, which were September 2003 and August 2007.
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were reported to currently have the condition. Of 
those with current ADHD, nearly half (46.7%) had 
mild ADHD, with the remainder having moderate 
(39.5%) or severe (13.8%) ADHD. ADHD (ever) 
was more than twice as common among boys as girls 
(13.2% versus 5.6%). High rates of ADHD (ever) 
were noted among multiracial children (14.2%) and 
children covered by Medicaid (13.6%).
Among children with current ADHD, 66.3% 
were taking medication for the disorder. In total, 
4.8% of all children aged 4–17 years (2.7 million) 
were taking medication for ADHD. Among boys, 
the prevalence of medicated ADHD (current) was 
highest for boys 11–14 years. The rates of medicated 
ADHD (current) increased with age among girls. The 
proportion of children taking medication for ADHD 
increased with severity, from 56.4% among children 
with mild ADHD, to 71.6% among children with 
moderate ADHD and 85.9% among children with 
severe ADHD (p<0.0001). The national prevalence 
of ADHD (ever) increased significantly between the 
two surveys (from 7.8% to 9.5%; Table 2), even 
after adjustment for sociodemographics, equating 
to a 21.8% increase in 4 years, or an average annual 
increase of 5.5%. The national estimate of children 
aged 4–17 years with parent-reported ADHD (ever) 
increased from 4.4 million in 2003 to 5.4 million 
in 2007, an increase of approximately 1 million 
children. Compared with 2003, the 2007 rates were 
significantly higher for each subgroup, with three 
exceptions: among households with less than a high 
TABLE 2. Weighted prevalence estimates and prevalence ratios of parent-reported 
attention-deficit/hyperactivity disorder (ADHD) among children 4–17 years,* by 
sociodemographic characteristics — National Survey of Children’s Health, United 
States, 2003 and 2007
Characteristic
Ever diagnosed with ADHD†
2003 2007
PR (95% CI) p value% %
Overall 7.8 9.5 1.22 (1.14–1.31) <0.001
Sex 
Male 11.0 13.2 1.20 (1.11–1.30) <0.001
Female 4.4 5.6 1.28 (1.12–1.46) <0.001
Age group (yrs)§ 
 4–10 5.7 6.6 1.16 (1.03–1.30) 0.013
 11–14 9.8 11.2 1.14 (1.03–1.27) 0.016
 15–17 9.6 13.6 1.42 (1.25–1.61) <0.001
Highest education 
in household 
Less than high school 6.5 8.4 1.30 (0.99–1.69) 0.055
High school graduate 8.6 12.2 1.42 (1.24–1.63) <0.001
More than high school 7.6 8.7 1.15 (1.06–1.25) <0.001
Race 
White 8.6 9.9 1.15 (1.06–1.24) <0.001
Black 7.7 10.1 1.31 (1.09–1.57) 0.004
Multiracial 9.7 14.2 1.46 (1.07–2.00) 0.017
Other 4.5 5.0 1.11 (0.72–1.71) NS
Ethnicity 
Hispanic/Latino 3.7 5.6 1.53 (1.16–2.02) 0.002
Non-Hispanic/Latino 8.6 10.5 1.22 (1.14–1.31) <0.001
Primary language in home 
English 8.6 10.5 1.22 (1.14–1.30) <0.001
Any other language 1.3 2.3 1.82 (1.15–2.90) 0.011
Poverty level¶ 
 ≤100% 9.3 11.6 1.25 (1.06–1.47) 0.007
 >100% to ≤200% 7.9 10.3 1.31 (1.11–1.54) 0.001
 >200% 7.3 8.6 1.18 (1.08–1.29) <0.001
Any health-care coverage 
Yes 8.1 9.8 1.21 (1.13–1.30) <0.001
Medicaid 10.8 13.6 1.26 (1.12–1.41) <0.001
Non-Medicaid 7.0 8.1 1.16 (1.06–1.27) 0.001
No 4.9 6.7 1.38 (1.00–1.90) 0.050
Region
Northeast 7.4 9.4 1.27 (1.09–1.49) 0.003
Midwest 7.9 9.9 1.25 (1.13–1.39) <0.001
South 9.1 10.9 1.20 (1.09–1.32) <0.001
West 5.8 7.0 1.20 (0.96–1.51) NS
Abbreviations: CI = confidence interval; NS = not statistically significant (p≥0.1); PR = preva-
lence ratio (the ratio of the percentage of children with ADHD among the sociodemographic 
group in 2007 to the percentage of children with ADHD among the sociodemographic group 
in 2003).
* Estimates do not include children aged 2–3 years with reported ADHD diagnosis because 
small sample sizes yield substantial (>30%) relative standard errors in the 2003 survey 
sample.
† The analytic sample included totals of 79,264 children aged 4–17 years in 2003 and 73,123 
children aged 4–17 years in 2007.
§ A statistically significant interaction was noted (p=0.013) with the magnitude, but not direc-
tion, of change across time differing significantly by age group.
¶ Federal poverty level; multiple imputations were used for the 10.0% of the sample in 2003 
and 8.9% in 2007 for which reported household income was missing.
What is already known on this topic?
Attention-deficit/hyperactivity disorder (ADHD) is the 
most common neurobehavioral disorder of childhood 
and often persists into adulthood. A 2003 survey 
found an estimated 7.8% of children aged 4–17 years 
had ever been diagnosed with ADHD.
What is added by this report?
The prevalence of parent-reported ADHD among 
children aged 4–17 years increased 21.8% during 
2003–2007, from 7.8% to 9.5%. Among older teens, 
the increase was 42%, and among Hispanic children 
the increase was 53%.
What are the implications for public health practice?
Health practitioners should be aware of changes 
in the national, state, and demographic patterns of 
ADHD in the United States, and that an estimated 
1 million more children were reported with ADHD in 
2007 than in 2003.
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school education, “other” (not white or black) races, 
and those living in the western United States. The 
magnitude of increase was largest among older teens, 
multiracial and Hispanic children, and children with 
a primary language other than English. A significant 
interaction was identified for age and survey year, with 
the rate of ADHD diagnosis (ever) increasing more 
for those in the oldest age group (15–17 years). The 
national increase in ADHD (ever) was reflected in 
significant increases within 12 states (Table 3).
Reported by
SN Visser, MS, RH Bitsko, PhD, ML Danielson, 
MSPH, R Perou, PhD, Div of Human Development 
and Disability, National Center on Birth Defects and 
Developmental Disabilities; SJ Blumberg, PhD, Div of 
Health Interview Statistics, National Center for Health 
Statistics, CDC.
Editorial Note
The findings in this report demonstrate a sub-
stantial increase in the percentage of children ever 
diagnosed with ADHD (according to parent report), 
with nearly one in 10 children aged 4–17 years diag-
nosed with ADHD by 2007. The overall estimate for 
the prevalence of children with a history of ADHD 
diagnosis in 2007 was higher than a recent estimate 
(8.4% of children aged 6–17 years) based on annual 
data from the 2004–2006 National Health Interview 
Survey (NHIS) (2). The NHIS report documented an 
average annual increase in diagnosed ADHD (ever) 
of 3% from 1997 to 2006; this present report docu-
ments a greater average annual increase (5.5%) over 
a slightly later period (2003–2007). The differences 
might reflect the inclusion of more recent data in this 
present report or differences in survey methods.
The increase in ADHD diagnosis (ever) over time 
was seen among all sociodemographic groups studied. 
The increases among Hispanic children and older 
teens were of particular interest. Although rates among 
Hispanics remained lower than non-Hispanics, the 
prevalence of ever receiving an ADHD diagnosis 
among Hispanic children was 53% higher in 2007 
than in 2003. This might indicate a shift in the cul-
tural acceptance of ADHD or changes in access to care 
(7,8). The magnitude of change by age over time was 
greatest among the oldest children (ages 15–17 years). 
Additional studies are needed to explain why increases 
in the prevalence of ADHD among older children are 
outpacing those of younger children. Twelve states 
TABLE 3. Weighted percentage of children aged 4–17 years with parent-reported 
attention-deficit/hyperactivity disorder (ADHD), by state — United States, 2003 
and 2007
State/Area




% (95% CI) % (95% CI)
Alabama 11.1 (9.3–13.2) 14.3 (11.8–17.2) NS
Alaska 7.1 (5.8–8.7) 9.2 (7.2–11.6) NS
Arizona 5.9 (4.6–7.5) 7.6 (5.9–9.7) NS
Arkansas 9.9 (8.3–11.8) 13.1 (11.0–15.6) 32.3
California 5.3 (4.2–6.7) 6.2 (4.1–9.1) NS
Colorado 5.0 (3.8–6.4) 7.6 (5.8–9.8) 52.0
Connecticut 7.3 (6.0–9.0) 7.8 (6.3–9.6) NS
Delaware 9.8 (8.1–11.7) 14.1 (11.8–16.8) 43.9
District of Columbia 6.7 (5.3–8.6) 7.7 (6.1–9.7) NS
Florida 9.2 (7.6–11.2) 11.6 (8.8–15.1) NS
Georgia 9.4 (7.7–11.4) 9.2 (7.3–11.4) NS
Hawaii 6.2 (4.8–7.8) 6.3 (4.9–8.1) NS
Idaho 6.4 (5.1–8.0) 8.3 (6.6–10.3) NS
Illinois 6.3 (5.0–7.9) 6.2 (4.9–7.9) NS
Indiana 7.9 (6.5–9.7) 13.2 (10.7–16.1) 67.1
Iowa 8.4 (6.8–10.2) 9.7 (7.4–12.7) NS
Kansas 8.1 (6.6–10.0) 10.0 (8.2–12.1) NS
Kentucky 10.1 (8.4–12.2) 12.4 (10.5–14.7) NS
Louisiana 10.3 (8.7–12.2) 14.2 (11.6–17.3) 37.9
Maine 7.9 (6.5–9.7) 9.6 (7.8–11.7) NS
Maryland 9.1 (7.7–10.8) 11.9 (9.8–14.5) NS
Massachusetts 8.5 (7.1–10.2) 9.8 (7.8–12.3) NS
Michigan 9.2 (7.7–11.0) 9.9 (8.0–12.2) NS
Minnesota 7.5 (6.1–9.2) 7.8 (6.2–9.8) NS
Mississippi 9.6 (7.9–11.6) 9.9 (8.1–11.9) NS
Missouri 7.7 (6.3–9.3) 10.8 (9.0–12.9) 40.3
Montana 7.1 (5.8–8.8) 8.5 (6.9–10.4) NS
Nebraska 6.4 (5.0–8.2) 9.0 (7.0–11.7) NS
Nevada 7.2 (5.9–8.8) 5.6 (4.0–7.8) NS
New Hampshire 9.2 (7.7–10.9) 8.5 (6.9–10.4) NS
New Jersey 7.2 (5.8–9.0) 9.0 (7.0–11.5) NS
New Mexico 6.1 (4.7–7.9) 7.1 (5.5–9.1) NS
New York 6.3 (4.9–8.0) 9.2 (7.1–11.7) 46.0
North Carolina 9.6 (8.0–11.4) 15.6 (13.0–18.5) 62.5
North Dakota 9.4 (7.7–11.4) 10.0 (8.2–12.0) NS
Ohio 8.9 (7.5–10.5) 13.3 (10.6–16.4) 49.4
Oklahoma 8.1 (6.5–9.9) 11.0 (8.9–13.4) 35.8
Oregon 7.2 (5.8–8.8) 8.8 (6.8–11.2) NS
Pennsylvania 8.2 (6.8–9.9) 10.2 (7.6–13.4) NS
Rhode Island 9.8 (8.1–11.8) 11.1 (9.0–13.5) NS
South Carolina 10.0 (8.4–11.8) 12.0 (9.9–14.5) NS
South Dakota 6.5 (5.0–8.3) 8.1 (6.6–10.1) NS
Tennessee 9.9 (8.1–12.0) 11.3 (9.2–13.8) NS
Texas 7.7 (6.3–9.3) 7.7 (5.7–10.4) NS
Utah 5.5 (4.2–7.1) 6.7 (5.1–8.7) NS
Vermont 6.9 (5.5–8.6) 9.9 (7.8–12.4) 43.5
Virginia 9.3 (7.7–11.1) 10.2 (8.4–12.3) NS
Washington 7.2 (5.8–8.9) 9.5 (7.3–12.2) NS
West Virginia 10.1 (8.4–12.1) 13.3 (11.1–15.8) 31.7
Wisconsin 8.1 (6.5–10.0) 9.9 (8.1–12.1) NS
Wyoming 7.1 (5.8–8.7) 9.1 (7.3–11.3) NS
Abbreviations: CI = confidence interval; NS = difference in rate of parent-reported ADHD (ever) 
was not statistically significant (p≥0.05).
* The percentage change (relative difference) between 2003 and 2007 for states with a 
statistically significant difference (p<0.05).
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had significant increases in ADHD (ever diagnosed). 
Changes in the sociodemographic composition of 
states or state-based policy or practice changes, such 
as widespread behavioral health screening, might have 
contributed to the increasing rates.
The findings in this report are subject to at least 
five limitations. First, ADHD status was based on 
parental report, requiring that the parent correctly 
recall a past or current ADHD diagnosis and make a 
judgment as to the disorder’s severity. Second, current 
ADHD, which might have incurred less recall bias, 
was not added to the survey until 2007, making it 
impossible to compare current ADHD prevalence 
across time using these data. Third, comparing esti-
mates of ADHD medication treatment across time 
also is problematic, because questions about ADHD 
medication treatment were asked of different sub-
groups (ever diagnosed in 2003 versus only current 
ADHD in 2007) across the two surveys. Fourth, 
the survey sample did not include families without 
landline telephones or those who elected not to par-
ticipate; however, noncoverage and nonresponse bias 
was reduced through sampling weight adjustments. 
Finally, the annual rate increases noted in this report 
represent an average for the 4-year period between 
surveys rather than observed annual rate increases 
because annual data were not available.
ADHD has a multidimensional effect on a person’s 
daily life functioning, and can culminate in significant 
costs attributable to greater health-care needs, more 
frequent unintentional injury, co-occurring psychiat-
ric conditions, and work loss (9). ADHD medications 
can reduce symptoms, but might be associated with 
side effects and might not completely address func-
tional impairment. Earlier reports also have noted 
increases in ADHD prevalence (2); However, this 
study demonstrated an increase in parent-reported 
ADHD prevalence across time for every demographic 
group studied.The highest rates of ADHD diagnosis 
(ever) in 2007 were among multiracial children and 
those with Medicaid coverage. Increasing rates of 
estimated ADHD prevalence might indicate an actual 
increase in the number of cases of ADHD or changes 
in diagnostic practice over time, which might have 
been influenced by increased awareness of the disorder 
over the period of study. Additional studies are needed 
to understand other geographic or environmental risk 
factors associated with rates of ADHD diagnosis, 
such as state-based policy and health-care provider 
characteristics (10). Ongoing surveillance is critical 
to understanding the public health effect of ADHD 
and the needs of a growing number of families affected 
by this disorder.
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Neonatal mortality is disproportionately common 
among infants with very low birth weight (VLBW) 
(<1,500 g [3.3 lbs]). In 2006, the mortality rate 
among infants with VLBW was 240.4 per 1,000 live 
births (1). Because neonatal intensive care has been 
shown to reduce mortality among infants with VLBW, 
current standards call for neonatal intensive-care for 
all infants with VLBW (2); however, the proportion 
of infants with VLBW who are admitted to a neonatal 
intensive care unit (NICU) is not known, nor are 
the predictors for NICU admission. To estimate the 
prevalence of admission to NICUs among infants with 
VLBW and assess factors predicting admission, CDC 
analyzed birth data from 2006 for 19 states (3). This 
report summarizes the results of that analysis, which 
found that overall, 77.3% of infants with VLBW were 
admitted to NICUs (range: 63.7% in California to 
93.4% in North Dakota). Among infants with VLBW 
born to Hispanic mothers, 71.8% were admitted to 
NICUs, compared with 79.5% of those with non-
Hispanic black mothers and 80.5% of those with 
non-Hispanic white mothers. Multivariate analysis 
of the data indicated that preterm delivery, multiple 
births, and cesarean delivery all were independently 
associated with greater prevalence of NICU admis-
sion among infants with VLBW. Wide variation was 
observed among states in the prevalence of NICU 
admission of infants with VLBW; these state data 
should be assessed further, and barriers to NICU 
admission should be identified and addressed.
Analyses were limited to live births to U.S. resi-
dents that occurred in the 19 states* that adopted the 
2003 revised birth certificate because earlier revisions 
of the birth certificate did not include information on 
NICU admission. The 19 states represented 49% of 
U.S. births in 2006, the most recent year for which 
data were available (3). The revised birth certificate 
collects information on maternal risk factors, obstetric 
history, newborn anthropometrics, and NICU admis-
sion. Instructions for completing the birth certificate 
define NICU admission as “admission into a facility 
or unit staffed and equipped to provide continuous 
mechanical ventilatory support for the newborn for 
at least 24 hours” (3). Prevalence estimates with 95% 
confidence intervals were calculated for NICU admis-
sion of infants with VLBW. Overall and pairwise (i.e., 
non-Hispanic white versus non-Hispanic black and 
non-Hispanic white versus Hispanic) differences in 
NICU admission by race/ethnicity were tested using 
chi-square analyses (with significance at p<0.05). 
Multivariate log-binomial regression was conducted 
to assess the independent associations between NICU 
admission of infants with VLBW and infant gesta-
tional age (in weeks, based on the date of last menses) 
and sex, and mother’s parity, race/ethnicity, age group, 
years of education, plurality, and delivery mode. 
Generalized estimating equations were used for mul-
tivariate models to account for variation among states 
in NICU admission of VLBW infants. Prevalence 
ratios and adjusted prevalence ratios (APRs) with 
95% confidence intervals were calculated.
Infants weighing <500 g typically are not admit-
ted to an NICU because they are not considered 
viable (4); therefore, these infants were excluded 
from analysis. Infants born to Asian/Pacific Islander 
and American Indian/Alaska Native women (1,252) 
and to women with unknown race/ethnicity (252) 
were included in descriptive analyses, but not in 
multivariate regression analyses. Prevalence estimates 
also were withheld, because of small numbers, for any 
state or category with <30 in either the numerator or 
denominator (0.6% of infants with VLBW).
In 2006, a total of 25,231 infants with VLBW 
were delivered in the 19-state reporting area; 19,512 
(77.3%) of these infants were admitted to NICUs 
(Table 1). Among the 19 states, the prevalence of 
NICU admission ranged from 63.7% in California to 
93.4% in North Dakota. Overall, a smaller percent-
age of infants with VLBW born to Hispanic mothers 
were admitted to NICUs than infants born to non-
Hispanic white or black mothers (71.8% compared 
with 80.5% and 79.5%, respectively). However, 
racial/ethnic differences in NICU admission varied 
by state.
Using multivariate analysis, three factors were 
associated with greater prevalence of NICU admission 
Neonatal Intensive-Care Unit Admission of Infants 
with Very Low Birth Weight — 19 States, 2006
* California, Delaware, Florida, Idaho, Kansas, Kentucky, Nebraska, 
New Hampshire, New York (excluding New York City), North 
Dakota, Ohio, Pennsylvania, South Carolina, South Dakota, 
Tennessee, Texas, Vermont, Washington, and Wyoming.
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among infants with VLBW: preterm delivery (<28 
weeks, APR = 1.32; 28–31 weeks, APR = 1.36; and 
32–36 weeks, APR = 1.27), multiple births (twins, 
APR = 1.04; triplets or more, APR = 1.08), and 
cesarean delivery (APR = 1.11) (Table 2). Multivariate 
analysis found no difference in the prevalence of 
NICU admission based on infant sex or maternal race/
ethnicity, parity, age group, or years of education.
Reported by
WD Barfield, MD, SE Manning, MD, C Kroelinger, 
PhD, Div of Reproductive Health, National Center 
for Chronic Disease Prevention and Health Promotion; 
JA Martin, MPH, Div of Vital Statistics, National 
Center for Health Statistics; DT Barradas, PhD, EIS 
Officer, CDC
Editorial Note
The findings in this report indicate that, overall in 
the 19 states sampled, 77.3% of infants with VLBW 
were admitted to NICUs in 2006, although the per-
centage of infants admitted to NICUs varied widely 
by state. Preterm delivery, multiple births, and cesar-
ean delivery were positively associated with VLBW 
infant NICU admission. Preterm infants and those 
from multiple births might be perceived as needing 
more specialized care than term or singleton infants 
(5), which might explain why they were found more 
likely to be admitted to an NICU in this analysis. 
Infants with VLBW delivered by cesarean might have 
had medical indications that led to choosing cesar-
ean delivery (e.g., congenital cardiac or respiratory 
abnormalities), and those indications also might have 
made them more likely to be admitted to an NICU. 
In addition, multiple births and cesarean deliveries 
might be more common at facilities with NICUs.
The American Academy of Pediatrics classifica-
tion system for neonatal care facilities includes three 
distinct levels of care: level I (basic neonatal care), 
level II (specialty neonatal care), and level III (sub-
specialty [i.e., NICU] care) (2). Although all level 
III neonatal facilities include an NICU, all NICUs 
do not have a level III designation (certain NICUs 
offer level II care). Epidemiologic evidence indicates 
higher survival rates among infants with VLBW born 
at facilities offering level III care, compared with those 
born at facilities with lower levels of care or infants 
transferred after birth (6).
Two national performance measures and objec-
tives have been created to monitor improvements 
in the availability of neonatal intensive care. The 
Maternal and Child Health Bureau (MCHB) col-
lects state-level data on the percentage of infants with 
TABLE 1. Number and percentage of infants with very low birth weight (VLBW) (<1,500 g) admitted to neonatal intensive-care units (NICUs), by 
state and maternal race/ethnicity — 19 states, 2006
State
No. of infants 
with VLBW
No. and % admitted to NICUs
Total* White, non-Hispanic Black, non-Hispanic Hispanic
 No. % 95% CI†  No. % 95% CI†  No. % 95% CI†  No. % 95% CI†
Overall§ 25,231  19,512 77.3 (76.8–77.9)  8,579 80.5 (79.7–81.3)  5,053 79.5 (78.5–80.5)  4,819 71.8 (70.7–72.9)
California 5,965  3,801 63.7 (62.5–64.9)  1,036 68.1 (65.8–70.4)  451 60.4 (56.9–63.9)  1,788 62.1 (60.3–63.9)
Delaware 193  172 89.0 (84.5–93.4)  74 91.4 (85.3–97.5)  82 88.2 (81.6–94.8) —¶ —
Florida 3,306  2,718 82.2 (80.9–83.5)  943 82.1 (79.9–84.3)  1,098 81.8 (79.7–83.9)  602 82.4 (79.6–85.2)
Idaho 206  176 85.4 (80.5–90.2)  138 85.7 (80.3–91.1) — —  34 85.0 (73.9–96.1)
Kansas 411  331 80.7 (76.9–84.5)  227 84.4 (80.1–88.7)  52 75.4 (65.2–85.6)  45 71.4 (60.2–82.6)
Kentucky 647  573 88.6 (86.1–91.0)  423 87.8 (84.9–90.7)  120 90.2 (85.1–95.3) — —
North Dakota 82  77 93.4 (87.8–99.0)  67 93.1 (87.2–99.0) — — — —
Nebraska 276  232 84.3 (79.9–88.6)  172 86.9 (82.2–91.6) — — — —
New Hampshire 121  102 84.3 (77.8–90.8)  90 84.1 (77.2–91.0) — — — —
New York** 1,588  1,401 88.2 (86.6–89.8)  840 88.1 (86.0–90.2)  325 88.1 (84.8–91.4)  188 90.0 (85.9–94.1)
Ohio 1,991  1,534 77.0 (75.2–78.9)  990 79.1 (76.8–81.4)  465 73.6 (70.2–77.0)  48 78.7 (68.4–89.0)
Pennsylvania 1,998  1,667 83.4 (81.8–85.0)  985 86.0 (84.0–88.0)  492 82.1 (79.0–85.2)  120 75.5 (68.8–82.2)
South Carolina 944  815 86.4 (84.2–88.6)  304 86.9 (83.4–90.4)  461 87.0 (84.1–89.9)  33 76.7 (64.1–89.3)
South Dakota 111  104 92.8 (87.2–98.3)  65 91.6 (85.1–98.1) — — — —
Tennessee 1,316  1,132 86.0 (84.1–87.9)  633 86.8 (84.3–89.3)  412 84.8 (81.6–88.0)  68 88.3 (81.1–95.5)
Texas 5,266  4,107 78.1 (76.9–79.2)  1,246 76.1 (74.0–78.2)  1,018 82.0 (79.9–84.1)  1,717 77.1 (75.4–78.8)
Vermont 57  45 79.0 (68.4–89.5)  44 80.0 (69.4–90.6) — — — —
Washington 726  518 71.5 (68.2–74.8)  299 73.5 (69.2–77.8)  38 55.9 (44.1–67.7)  108 77.7 (70.8–84.6)
 * Includes 1,252 births to Asian/Pacific Islander and American Indian/Alaska Native women and 252 births to women with unspecified race/ethnicity. 
 † Confidence interval.
 § Because of small numbers, stratified data for Wyoming infants are not shown, but are included in the overall estimates.
 ¶ Data excluded because cell size <30.
 ** Excludes New York City.
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to 90% the percentage of infants with VLBW born 
at level III hospitals or subspecialty perinatal centers 
(9). This target is a 23% increase from the baseline 
of 73% reported in the Title V reporting system 
during 1996–1997. Current perinatal standards of 
care recommend admission of all viable infants with 
VLBW born in a level III facility into the NICU; 
those standards and the findings in this report should 
be considered in light of waning efforts in the United 
States to regionalize perinatal services, which would 
geographically distribute facilities in such a manner 
that mothers with high-risk pregnancies will be more 
likely to give birth in level III facilities.
The findings in this report are subject to at least 
three limitations. First, these data are representative 
VLBW delivered at facilities for high-risk deliveries 
and neonates (performance measure 17) through the 
Title V Reporting System (7). These data are provided 
by states and are generally based on birth certificate 
data. Although some differences exist in the propor-
tion of infants with VLBW receiving specialized care, 
the findings in this report are generally comparable 
to MCHB data. However, definitions, criteria, and 
regulation of hospital-based perinatal centers vary 
greatly (8); some states identify level II perinatal cen-
ters as “facilities for high-risk deliveries and neonates,” 
while others only include level III perinatal centers 
for this indicator.
In addition to MCHB performance measure 17, 
Healthy People 2010 objective 16-8 seeks to increase 
TABLE 2. Number (n = 22,427) and percentage of infants with very low birth weight (<1,500 g) admitted to neonatal intensive-care units (NICUs), 
by selected characteristics — 19 states,* 2006
Characteristic
Bivariate analysis Multivariate analysis†
No. % (95% CI) PR (95% CI) APR (95% CI)
Infant gestational age (wks)
 <28 8,477 77.4 (76.5–78.3) 1.39 (1.31–1.47) 1.32 (1.21–1.44)
 28–31 9,347 82.9 (82.1–83.7) 1.49 (1.41–1.57) 1.36 (1.25–1.48)
 32–36 3,597 76.1 (75.2–78.0) 1.36 (1.29–1.45) 1.27 (1.17–1.37)
 ≥37 1,006 55.8 (52.7–58.9) 1.00 Referent 1.00 Referent
Plurality
Singleton 16,694 76.8 (76.2–77.4) 1.00 Referent 1.00 Referent
Twin 4,798 82.3 (81.2–83.4) 1.07 (1.05–1.09) 1.04 (1.02–1.05)
Triplet or more 935 88.9 (86.9–90.9) 1.16 (1.13–1.19) 1.08 (1.01–1.15)
Delivery mode
Vaginal 7,060 71.4 (70.3–72.5) 1.00 Referent 1.00 Referent
Cesarean 15,367 81.8 (81.2–82.4) 1.15 (1.13–1.16) 1.11 (1.08–1.15)
Sex
Male 11,297 78.2 (77.4–79.0) 1.00 Referent 1.00 Referent
Female 11,130 78.8 (78.0–79.6) 1.01 (0.99–1.02) 1.00 (0.99–1.01)
Parity
 0 7,766 77.5 (76.6–78.4) 1.00 Referent 1.00 Referent
 1 5,733 79.6 (78.6–80.6) 1.03 (1.01–1.05) 1.01 (1.00–1.02)
 2 3,740 78.4 (77.1–79.7) 1.01 (0.99–1.03) 1.00 (0.98–1.02)
 ≥3 5,188 78.8 (77.7–79.9) 1.02 (0.99–1.04) 1.00 (0.98–1.01)
Maternal race/ethnicity
White, non-Hispanic 10,157 81.1 (80.3–81.9) 1.00 Referent 1.00 Referent
Black, non-Hispanic 5,946 80.6 (79.6–81.6) 0.99 (0.98–1.01) 1.00 (0.96–1.03)
Hispanic 6,324 72.3 (71.2–73.4) 0.89 (0.88–0.91) 1.00 (0.98–1.01)
Maternal age (yrs)
 <20 3,059 77.8 (76.3–79.3) 0.97 (0.98–0.99) 1.00 (0.98–1.02)
 20–24 5,554 77.0 (75.9–78.1) 0.96 (0.94–0.98) 0.97 (0.95–1.00)
 25–29 5,394 78.4 (77.3–79.5) 0.98 (0.96–0.99) 0.98 (0.97–1.00)
 30–34 4,673 80.1 (79.0–81.2) 1.00 Referent 1.00 Referent
 35–39 2,910 79.9 (78.4–81.4) 1.00 (0.97–1.02) 1.00 (0.97–1.02)
 ≥40 837 78.0 (75.2–80.8) 0.97 (0.94–1.01) 0.99 (0.95–1.03)
Maternal educational attainment (yrs)
 <12 6,240 73.7 (72.6–74.8) 0.92 (0.90–0.94) 0.97 (0.93–1.00)
 12 6,273 80.0 (79.0–81.0) 1.00 Referent 1.00 Referent
 13–15 5,827 80.1 (79.1–81.1) 1.00 (0.97–1.02) 0.99 (0.98–1.02)
 ≥16 4,087 81.1 (79.9–82.3) 1.01 (0.99–1.03) 0.99 (0.98–1.00)
Abbreviations: APR = adjusted prevalence ratio; CI = confidence interval; PR = prevalence ratio.
* California, Delaware, Florida, Idaho, Kansas, Kentucky, Nebraska, New Hampshire, New York (excluding New York City), North Dakota, Ohio, Pennsylvania, South Carolina, South Dakota, 
Tennessee, Texas, Vermont, Washington, and Wyoming.
† To produce APR, variables were adjusted for all other variables included in the model; generalized estimating equations were used to account for variation in NICU admissions among 
states.
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of 19 states and cannot be generalized to the entire 
U.S. population. Second, NICU admission is a new 
variable added to the revised birth certificate. The 
quality of this new variable has not yet been assessed. 
For example, these data cannot distinguish between 
NICU admission at the facility of birth and admission 
in another facility. Finally, NICU admission might 
be underreported overall or differentially reported by 
maternal or infant characteristics, including state of 
residence and race/ethnicity.
The survival rate is highest when infants with 
VLBW are born at level III facilities (6). A previous 
study showed that infants with VLBW who received 
NICU care, despite being born at a non-level III 
facility, were 24% more likely to survive than infants 
who did not receive NIUC care (10); however, 
another study found that infants with VLBW who 
are born at a level III facility were 51% more likely 
to survive than infants born at a lower-level facility 
(6). Therefore, the ultimate goal of regionalization of 
perinatal services should be to ensure that mothers 
with high-risk pregnancies deliver their children in 
level III facilities with access to NICU services at birth. 
Understanding barriers to admission of infants with 
VLBW into NICUs could provide guidance for shap-
ing perinatal care infrastructure and practices within 
states. Future studies should evaluate the validity of 
the NICU admission item on the birth certificate 
and provide suggestions for how data quality might 
be improved.
References
 1. Matthews TJ, MacDorman MF. Infant mortality statistics 
from the 2006 period linked birth-infant death dataset. Natl 
Vital Stat Rep 2010;58(17).
 2. American Academy of Pediatrics and the American College 
of Obstetricians and Gynecologists. Guidelines for perinatal 
care. 6th ed. Elk Grove Village, IL: American Academy of 
Pediatrics; 2007.
 3. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data 
for 2006. Natl Vital Stat Rep 2009;57(7).
 4. Donohue PK, Boss RD, Shepard J, Graham E, Allen MC. 
Intervention at the border of viability: perspective over a 
decade. Arch Pediatr Adolesc Med 2009;163:902–6.
 5. Lee SK, Penner PL, Cox M. Comparison of the attitudes of 
health care professionals and parents toward active treatment 
of infants with VLBW. Pediatrics 1991;88:110–4.
 6. Lasswell SM, Barfield WD, Rochat RW, Blackmon L. Perinatal 
regionalization for very low-birth-weight and very preterm 
infants: a meta-analysis. JAMA 2010;304:992–1000.
 7. Maternal and Child Health Bureau. Title V Information 
System: national performance measures. Rockville, MD: US 
Department of Health and Human Services, Health Resources 
and Services Administration, Maternal and Child Health 
Bureau; 2010. Available at https://perfdata.hrsa.gov/mchb/
tvisreports/measurementdata/measurementdatamenu.aspx. 
Accessed November 4, 2010.
 8. Blackmon LR, Barfield WD, Stark AR. Hospital neonatal 
services in the United States: variation in definitions, criteria, 
and regulatory status, 2008. J Perinatol 2009;29:788–94.
 9. US Department of Health and Human Services. Maternal, 
infant, and child health. Objective 16-8: increase the 
proportion of very low birth weight (VLBW) infants born at 
level III hospitals or subspecialty perinatal centers. Healthy 
People 2010 (conference ed, in 2 vols). Washington DC: 
US Department of Health and Human Services; 2000. 
Available at http://www.healthypeople.gov/document/html/
volume2/16mich.htm. Accessed November 4, 2010.
 10. Cifuentes J, Bronstein J, Phibbs CS, Phibbs RH, Schmitt SK, 
Carlo WA. Mortality in low birth weight infants according 
to levels of neonatal care at hospital of birth. Pediatrics 
2002;109:745–51.
What is already known on this topic?
Neonatal intensive-care unit (NICU) admission at birth 
for infants with very low birth weight (VLBW) can 
reduce their risk for mortality.
What is added by this report?
Among the 19 states with data available (having 
adopted the 2003 revision of the birth certificate), 
77.3% of infants with VLBW overall were admitted 
to NICUs; however, the proportion varied widely by 
state. In addition, preterm delivery, multiple births, 
and cesarean delivery all were associated with greater 
prevalence of NICU admission.
What are the implications for public health practice?
Given the wide variability in NICU care of infants with 
VLBW among states, any barriers to infants being 
admitted to NICUs should be identified and addressed 
at the state level to reduce mortality among infants in 
this high-risk group.
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Millions of persons in the United States have no 
health insurance. In addition to paying for their health 
care out of pocket, uninsured persons often are charged 
significantly higher fees than insured persons for the 
same care because of insurance plan discounts nego-
tiated with health-care providers (1). Consequently, 
uninsured persons forgo needed care, including pre-
ventive care, because of cost concerns (2,3). Absent 
or delayed health care can lead to poorer health and 
potentially to greater medical expenditures in the long 
term (4,5). Although Medicare provides near-universal 
health insurance coverage for persons aged ≥65 years, 
and expansions in Medicaid and the Children’s Health 
Insurance Program have increased coverage for chil-
dren in the United States, a substantial percentage of 
adults aged 18–64 years have experienced disruptions 
in access to health care during the past decade, includ-
ing those with chronic conditions, who have a greater 
need for care than the general population (6). In this 
report, CDC uses NHIS data to assess the association 
between lack of health insurance coverage and delaying 
or forgoing health care.
Methods
NHIS data regarding health insurance status and 
health-care utilization were collected via in-person 
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interviews of a sample of the noninstitutionalized 
civilian population. Persons were considered unin-
sured if they did not have private health insurance, 
Medicare, Medicaid, Children’s Health Insurance 
Program insurance, a state-sponsored or other 
government-sponsored health plan, or a military 
plan. Persons also were defined as uninsured if they 
had only a private plan that paid for one type of 
coverage (e.g., injury, eye care, or dental care) or had 
only Indian Health Service coverage.* Participants 
were asked whether they had insurance at the time 
of interview; whether they had been uninsured for at 
least part (i.e., even if only 1 day) of the preceding 
12 months and, if so, for how long; whether they 
had delayed or forgone health care because of cost 
in the preceding 12 months†; whether they had ever 
been diagnosed with hypertension, diabetes mellitus, 
or asthma; and whether they had a usual source of 
care. Persons reporting that they typically visited an 
emergency department were considered not to have 
a usual source of care.
Of the households contacted, 82.2% participated 
in the 2009 survey. The response rate from partici-
pants exceeded 98% for the questions that produced 
the findings in this report, except for questions on 
income and race/ethnicity. Multiple imputations were 
performed on family§ income and personal earnings 
data and hot-deck imputations were performed on 
race/ethnicity data to account for missing responses 
to these questions.¶ NHIS data were adjusted for 
nonresponse and weighted to provide national esti-
mates of insurance status, usual source of care, and 
care utilization; 95% confidence intervals were cal-
culated, taking into account the survey’s multistage 
probability sample design. The Wald test and logistic 
regression analyses were used to identify the statistical 
significance of differences in care utilization between 
persons who were continuously insured and those 
with either a 1–3 month gap in coverage in the preced-
ing 12 months or with no health insurance for >12 
months before the interview. Insurance status, usual 
source of care, and care utilization were examined by 
age group, sex, race/ethnicity, income level, and the 
highest level of education attained in the family. Data 
from the final release 2009 NHIS and early release 
NHIS data (i.e., compiled before final data editing 
and weighting) for the first quarter of 2010 were ana-
lyzed. Additional data from NHIS for 2006, 2007, 
and 2008 were used for comparison purposes.
Results
In 2009, an estimated 58.7 million (19.5%) per-
sons of all ages had no health insurance for at least 
part of the year preceding their interview (Table 1). 
Of these 58.7 million, 48.6 million (82.8%) were 
persons aged 18–64 years, and 9.5 million (16.2%) 
were persons aged ≤17 years. From 2008 to 2009, the 
number of children without coverage for at least part 
of the year decreased 5.0%, from 10.0 million to 9.5 
million. In contrast, the number of adults aged 18–64 
years in this same insurance category increased 5.7%, 
from 46.0 million to 48.6 million. In 2009, 25.7% 
of all adults aged 18–64 years were without coverage 
for at least part of the preceding year; 15.4% reported 
being uninsured for more than a year (Table 1).
In the first quarter of 2010, the estimated number 
of persons without coverage for at least part of the year 
increased by 400,000 (0.7%), from 2009 to 59.1 mil-
lion. The number of persons aged 18–64 years without 
coverage for at least part of the year increased by 1.3 
million (2.7%) to 49.9 million, and the number 
without coverage for more than a year increased by 
1.3 million (4.5%) to 30.4 million (Table 1).
In 2009, among persons aged 18–64 years with 
family incomes two to three times the federal poverty 
level (approximately $43,000–$65,000 for a family of 
four),** 9.7 million (32.1%) were uninsured for at least 
part of the preceding year. Among persons aged 18–64 
years with family incomes three to four times the fed-
eral poverty level (approximately $65,000–$87,000 for 
a family of four), 5.2 million (20.6%) were uninsured 
for at least part of the preceding year (Table 2). From 
2006 to 2009, the largest increase of any income group 
in the number (from 8.0 million to 9.7 million) and 
* Consistent with other population surveys conducted by U.S. federal 
agencies, CDC does not regard Indian Health Service coverage as health 
insurance for the purpose of identifying uninsured populations.
† Participants were asked two different questions: “During the past 12 
months, has [person] delayed seeking medical care because of worry 
about the cost?” and “During the past 12 months, was there any 
time when [person] needed medical care but did not get it because 
[person] couldn’t afford it?” Additional information available at 
http://www.cdc.gov/nchs/nhis/nhis_2009_data_release.htm.
§ The 2009 NHIS defined a family as “an individual or group of 
two or more related persons who are living together in the same 
occupied housing unit (i.e., household) in the sample. In some 
instances, unrelated persons sharing the same household may also 
be considered as one family, such as unmarried couples who are 
living together.” Additional information available at http://www.
cdc.gov/nchs/nhis/quest_data_related_1997_forward.htm.
¶ Additional information available at http://www.cdc.gov/nchs/nhis/ 
2009imputed income.htm.
 ** Additional information available at http://www.census.gov/hhes/
www/poverty/about/overview/measure.html.
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percentage (27.8% to 32.1%) of adults aged 18–64 
without insurance at some point during the prior year 
occurred among those with a family income of two to 
three times the federal poverty level.
Persons aged 18–64 years who were without health 
insurance for more than a year were approximately 
six times as likely (55.2% versus 9.3%) to not have a 
usual source of care, compared with those who were 
continuously insured (Table 3). Similarly, persons 
aged 18–64 years with no health insurance during the 
preceding year were seven times as likely (27.6% versus 
4.0%) to forgo needed health care because of cost, 
compared with those continuously insured (Table 4). 
Persons aged 18–64 years with no health insurance 
during the preceding year were approximately six times 
as likely to forgo needed care if they had hypertension 
(42.7% versus 6.7%) or diabetes mellitus (47.5% versus 
7.7%) and five times as likely (40.8% versus 8.0%) to 
forgo needed care if they had asthma, compared with 
those with continuous coverage who had the same 
chronic condition (Table 4).
Currently insured persons aged 18–64 years who 
had a 1–3 month gap in coverage during the preceding 
year were nearly twice as likely (16.4% versus 9.3%) 
to not have a usual source of care, and three times as 
likely (26.5% versus 7.1%) to delay care because of 
cost, compared with persons with continuous cover-
age (Table 3). Currently insured persons aged 18–64 
years who had a 1–3 month gap in coverage during the 
preceding year were approximately four times as likely 
(16.4% versus 4.0%) to forgo needed care because of 
cost, compared with persons with continuous coverage 
(Table 4). Among persons aged 18–64 years with con-
tinuous coverage, those with family income less than 
or equal to twice the federal poverty level were twice as 
likely (7.7% versus 3.1%) to forgo needed care because 
of cost as those with continuous coverage and income 
greater than twice the poverty level (Table 4).
TABLE 2. Number* and percentage of persons aged 18–64 years with no health insurance coverage for at least part of the 
12 months† before interview, by household income level — National Health Interview Survey, United States, 2006–2009
Annual family income relative to the 
federal poverty level§
2006 2007 2008 2009
No. in millions (%) No. in millions (%) No. in millions (%) No. in millions (%)
 ≤100%  11.4 (47.2)  10.0 (45.5)  10.1 (45.3)  11.8 (49.1)
 101%–200%  13.6 (43.2)  13.9 (44.0)  14.2 (46.0)  15.2 (45.9)
 201%–300%  8.0 (27.8)  8.9 (29.9)  8.9 (29.8)  9.7 (32.1)
 301%–400%  4.8 (18.6)  5.2 (20.0)  5.3 (20.3)  5.2 (20.6)
 >400%  7.5 (10.0)  6.8 (8.8)  7.6 (9.7)  6.9 (9.0)
Total  45.2 (24.4)  44.8 (23.9)  46.0 (24.5)  48.6 (25.7)
* Numbers might not sum to totals because of rounding.
† No insurance even if only for 1 day.
§ In 2009, the poverty level for a family with two adults and two children was $21,756. Additional information available at http://www.census.
gov/hhes/www/poverty/about/overview/measure.html.
TABLE 1. Number and percentage of persons with no health insurance coverage for at least part of the 12 months before 
interview* or for >12 months before interview, by age group — National Health Interview Survey, United States, 2008, 
2009, and January–March 2010
2008 2009 January–March 2010†
Age group/Insurance status No. in millions (%) No. in millions (%) No. in millions (%)
≤17 yrs
 No health insurance for at least part of the 12 mos before 
interview
 10.0 (13.5)  9.5 (12.8)  8.7 (11.7)
 No health insurance for >12 mos before interview  4.1 (5.6)  3.6 (4.8)  3.4 (4.6)
18–64 yrs
 No health insurance for at least part of the 12 mos before 
interview
 46.0 (24.5)  48.6 (25.7)  49.9 (26.2)
 No health insurance for >12 mos before interview  27.5 (14.6)  29.1 (15.4)  30.4 (16.0)
All ages
 No health insurance for at least part of the 12 mos before 
interview
 56.4 (18.9)  58.7 (19.5)  59.1 (19.5)
 No health insurance for >12 mos before interview  31.7 (10.6)  32.8 (10.9)  33.9 (11.2)
* No insurance even if only for 1 day.
† Early release of estimates. Additional information available at http://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201009.htm.
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versus 7.7%), or asthma (26.0% versus 8.0%), compared 
with those with continuous coverage who had the same 
chronic condition (Table 4).
Among persons aged 18–64 years, those who 
were uninsured at the time of the interview were 
approximately three times as likely to forgo needed 
care because of cost as those with Medicaid (26.3% 
versus 8.7%) at the time of interview and six times 
as likely to forgo needed care because of cost as those 
with private insurance (26.3% versus 4.2%) at the 
time of interview (Table 5). Persons aged 18–64 years 
living in a family in which no one had a high school 
diploma or equivalent were approximately four times 
as likely to forgo needed care because of cost as those 
living in a family with a holder of a graduate degree 
(16.3% versus 4.2%) (Table 5).
Among those aged 18–64 years with family income 
less than or equal to twice the federal poverty level, 
currently insured persons who had a 1–3 month gap in 
coverage during the preceding year were approximately 
three times as likely (21.0% versus 7.7%) to forgo 
needed health care, compared with those with continu-
ous coverage. Among those with income greater than 
twice the poverty level, currently insured persons who 
had a 1–3 month gap in coverage during the preceding 
year were four times as likely (13.8% versus 3.1%) to 
forgo needed health care, compared with those with 
continuous coverage (Table 4). Currently insured per-
sons aged 18–64 years who had a 1–3 month gap in 
coverage during the preceding year were approximately 
three times as likely to forgo needed care if they had 
hypertension (25.3% versus 6.7%), diabetes (30.8% 
TABLE 4. Percentage of adults aged 18–64 years who chose to forgo needed health care because of cost during the 12 
months before interview, by selected health insurance status, chronic conditions, and household income level — National 
Health Interview Survey, United States, 2009
Chronic condition*
Annual household 




during 12 months 
before interview
%
Currently insured, but had a 1–3 
month gap in coverage during the 
12 months before interview
%
No health insurance 
for >12 months before 
interview
%
Total population aged 18–64 yrs ≤200% 7.7 21.0§ 28.1§
>200% 3.1 13.8§ 22.6§
All income levels 4.0 16.4§ 27.6§
Hypertension ≤200% 13.2 28.4 49.1§
>200% 4.6 23.6§ 31.6§
All income levels 6.7 25.3§ 42.7§
Diabetes mellitus ≤200% 12.8 —¶ 47.9§
>200% 5.1 — 46.8**
All income levels 7.7 30.8** 47.5§
Asthma ≤200% 12.3 41.9§ 44.5§
>200% 6.2 17.2 36.1§
All income levels 8.0 26.0§ 40.8§
 * In the total population aged 18–64 years, 23.1% reported having been diagnosed with hypertension, 13.8% with asthma, and 7% with diabetes.
 †  In 2009, the poverty level for a household with two adults and two children was $21,756. Additional information available at http://www.census.gov/hhes/www/
poverty/about/overview/measure.html.
 § Significantly different from the percentage for continuous coverage (p<0.005).
 ¶ Data not reported because of standard error >30%.
 ** Significantly different from the percentage for continuous coverage (p<0.05).
TABLE 3. Percentage of adults aged 18–64 years who did not have a usual source of health care or who delayed care 
because of cost during the 12 months before interview, by selected health insurance status — National Health Interview 
Survey, United States, 2009
Health-care characteristic
Continuously insured 
during 12 months 
before interview
%
Currently insured, but had 
a 1–3 month gap in cover-
age during the 12 months 
before interview
%
No health insurance 
for >12 months 
before interview
%
No usual source of health care, 
excluding emergency room
9.3 16.4* 55.2*
Delayed health care because of cost 7.1 26.5* 32.3*
* Significantly different from the percentage for continuous coverage (p<0.005).
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Conclusions and Comments
This report indicates that an increasing proportion 
of persons aged 18–64 years in the United States lack 
health insurance, even for brief periods, and that gaps 
in insurance coverage are associated with delaying or 
forgoing health care, irrespective of family income 
level. These findings are particularly important for 
persons with chronic diseases. Approximately 40% 
of persons in the United States have one or more 
chronic diseases, and continuity in the health care they 
receive is essential to prevent complications, avoidable 
long-term expenditures, and premature mortality 
(6). The number of uninsured persons increased in 
2009 and the first quarter of 2010, but the Affordable 
Care Act of 2010 (ACA) is projected to reverse this 
trend by extending insurance coverage to 94% of the 
nonelderly population by 2019 (7).
The data in this report support previous findings 
that continuous insurance coverage is an important 
factor in reducing delayed or forgone health care, 
which other studies have associated with avoidable 
hospitalizations for persons with chronic conditions 
(8). In addition, the data demonstrate that cost 
can be a barrier to health care, even for those with 
insurance coverage. Increasing the number of per-
sons who receive five high-value prevention services 
(i.e., smoking cessation assistance, colorectal cancer 
screening, breast cancer screening, annual influenza 
TABLE 5.  Percentage of persons who had a usual source of health care, who delayed care because of cost, or who went 
without some needed health care because of cost during the 12 months before interview, by age group and selected 
characteristics — National Health Interview Survey, United States, 2009
Age group/Characteristic
Had usual source of 
health care, excluding 
emergency room
Delayed health care 
because of cost
Went without some 
needed health care 
because of cost
% (95% CI) % (95% CI) % (95% CI)
≤17 yrs
 Sex
  Men 95.1 (94.5–95.8) 4.7 (4.1–5.2) 2.5 (2.1–2.9)
  Women 95.6 (95.1–96.2) 4.8 (4.1–5.4) 2.5 (2.1–2.8)
 Race/Ethnicity
  Hispanic 92.1 (90.9–93.2) 5.9 (4.8–7.1) 3.7 (2.9–4.4)
  White, non-Hispanic 96.5 (96.0–97.1) 4.4 (3.7–5.1) 1.9 (1.5–2.3)
  Black, non-Hispanic 95.5 (94.4–96.5) 4.5 (3.7–5.4) 2.8 (2.1–3.5)
 Highest education level in family
  No high school diploma 90.0 (88.0–92.0) 5.0 (3.8–6.1) 3.4 (2.4–4.3)
  High school diploma or GED 95.0 (94.3–95.6) 5.9 (5.0–6.7) 2.9 (2.4–3.4)
  Bachelor’s degree 97.2 (96.3–98.0) 3.4 (2.7–4.1) 1.9* (1.3–2.5)*
  Graduate degree 97.6 (96.7–98.4) 2.2* (1.5–2.9)* 1.1* (0.6–1.6)*
 Health insurance status at interview
  Uninsured 74.7 (71.6–77.9) 22.6 (19.7–25.5) 13.8 (11.8–15.8)
  Medicaid 96.2 (95.4–97.1) 3.1 (2.3–3.9) 1.9* (1.4–2.5)*
  Private insurance 97.7 (97.3–98.2) 3.3 (2.7–3.8) 1.3 (1.0–1.7)
18–64 yrs
 Sex
  Men 75.2 (74.1–76.4) 12.2 (11.6–12.7) 8.9 (8.4–9.4)
  Women 86.7 (85.9–87.5) 14.4 (13.9–15.0) 10.2 (9.7–10.7)
 Race/Ethnicity
  Hispanic 69.8 (67.9–71.7) 13.5 (12.6–14.5) 11.1 (10.3–12.0)
  White, non-Hispanic 83.6 (82.7–84.5) 13.4 (12.9–14.0) 9.0 (8.5–9.5)
  Black, non-Hispanic 82.0 (80.5–83.5) 14.0 (12.9–15.1) 12.2 (11.1–13.2)
 Highest education level in family
  No high school diploma 67.1 (64.5–69.8) 17.6 (16.0–19.2) 16.3 (14.7–17.8)
  High school diploma or GED 79.9 (78.9–80.8) 15.9 (15.2–16.5) 11.9 (11.3–12.4)
  Bachelor’s degree 85.3 (84.0–86.6) 10.2 (9.3–11.0) 5.9 (5.3–6.4)
  Graduate degree 88.7 (87.0–90.3) 7.4 (6.5–8.2) 4.2 (3.6–4.8)
 Health insurance status at interview
  Uninsured 48.5 (46.8–50.2) 31.5 (30.3–32.7) 26.3 (25.1–27.4)
  Medicaid 90.8 (89.1–92.5) 10.9 (9.5–12.3) 8.7 (7.5–9.8)
  Private insurance 89.7 (89.0–90.4) 7.8 (7.4–8.2) 4.2 (3.9–4.5)
Abbreviations: CI = Confidence interval; GED = General Education Development.
* Estimates have a relative standard error between 30% and 50% and should be used with caution.
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immunization, and daily aspirin to prevent heart 
disease) could save an estimated 100,000 lives each 
year (9). By requiring insurance coverage and no cost-
sharing for these and other recommended prevention 
services,†† ACA is projected to help increase the num-
ber of persons who receive preventive care.
Like insurance coverage, family income is an 
important influence on receipt of health care. The 
data show that among persons aged 18–64 years 
with continuous insurance coverage, those with lower 
family incomes are twice as likely to forgo needed 
care because of cost when compared to those with 
higher family incomes. This disparity in health-care 
utilization might result from multiple factors outside 
the scope of this analysis, including personal choice, 
underinsurance, more difficulty making copayments, 
and barriers to accessing care (e.g., transportation 
costs and physician acceptance of publicly insured 
patients). This report focuses on persons aged 18–64 
years and particularly those with chronic conditions, 
because these populations are large and their ability 
to receive all needed care has decreased substantially 
in recent years (6). As a result of near-universal cov-
erage of persons aged ≥65 years through Medicare 
and expansions in coverage for persons aged ≤17 
years through Medicaid and the Children’s Health 
Insurance Program, coverage for these age groups 
has improved or remained relatively stable in recent 
years.§§
The findings in this report are subject to at least 
two limitations. First, although the data show that 
insurance coverage is a key factor in receipt of health 
care, coverage alone does not guarantee receipt of 
care or even having a usual source of care. Whether a 
person has a usual source of care is dependent, in part, 
on personal and societal characteristics. For example, 
some healthy persons might not have a usual source 
of care because they have not needed care or have 
moved recently. Also, some persons might not attach 
importance to having a usual source of care, yet still 
might be able to receive any care they need. Second, 
the association between receipt of care and health 
outcomes is beyond the scope of this analysis. NHIS 
respondents were not asked to identify the nature, 
cost, frequency, or urgency of any medical care that 
they delayed or went without because of cost concerns. 
Delaying or forgoing certain health care on an infre-
quent basis might not negatively impact health.
Even after ACA is implemented fully, some per-
sons eligible for coverage might go uninsured. ACA 
is expected to extend Medicaid eligibility to a large 
number of persons, and 16 million are projected to 
enroll, which amounts to approximately half of the 
total insurance expansion estimated in response to 
the legislation (7). Some persons will be eligible for 
Medicaid but might remain uninsured. Studies have 
indicated that 60%–74% of children who are eligible 
Key Points
•	 In	 the	first	 quarter	 of	2010,	 approximately	
50 million (26%) persons aged 18–64 years 
had no health insurance for at least part of 
the 12 months preceding their interview, and 
30 million (16%) had no insurance for more 
than a year.
•	 From	2006	 to	2009,	 the	number	of	 adults	
aged 18–64 years without health insurance 
at some point during the prior year increased 
by an average of about 1.1 million per year. 
About half of the total increase occurred 
among those with family incomes two to three 
times the federal poverty level.
•	 Although	 lack	 of	 insurance	 can	 be	 linked	
to poverty, in 2009, 32% of persons aged 
18–64 years with family incomes two to three 
times the poverty level and 21% with family 
incomes three to four times the poverty level 
went without health insurance for part of the 
preceding 12 months.
•	 In	 2009,	 adults	 aged	 18–64	 years	with	no	
health insurance for the previous 12 months 
were seven times as likely to forgo needed 
health care because of cost as those with con-
tinuous insurance coverage.
•	 In	2009,	more	than	40%	of	adults	aged	18–64	
years who had high blood pressure, asthma, 
or diabetes and no health insurance went 
without some medical care because of cost 
during the preceding 12 months. 
•	 Additional	information	is	available	at	http://
www. cdc.gov/vitalsigns.
 §§ Additional information available at http://www.cdc.gov/nchs/data/
nhis/earlyrelease/insur201009.htm.
 †† Additional information available at http://www.healthcare.gov/
center/regulations/prevention/recommendations.html.
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for Medicaid are uninsured, in part as a result of failure 
to renew enrollment in Medicaid (10). Because ACA 
will require persons to obtain insurance coverage, the 
proportion of persons who are eligible for Medicaid 
but not enrolled likely will decline from current levels. 
Further efforts to increase enrollment and coverage 
retention for children and to add persons aged 18–64 
years who will be newly eligible for Medicaid could 
help these populations maintain continuous coverage, 
thereby increasing receipt of preventive services and 
reducing avoidable complications from illness, long-
term health-care costs, and premature deaths (10).
Reported by
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Get Smart About Antibiotics Week — 
November 15–21, 2010
November 15–21, 2010, is the third annual Get 
Smart About Antibiotics Week. This week focuses 
attention on the need to reduce antibiotic resistance 
by improving antibiotic use. Antibiotics are one of 
the most important tools available to combat life-
threatening bacterial diseases. However, increasing 
antibiotic resistance is compromising the effectiveness 
of antibiotics. In recognition of this as a global public 
health issue, Get Smart About Antibiotics Week will 
coincide with Antibiotic Awareness Day, November 
18, 2010, in the European Union and Canada.
CDC’s Get Smart: Know When Antibiotics Work 
and Get Smart for Healthcare programs are designed 
to educate consumers and health-care providers about 
appropriate use of antibiotics. Infections with resistant 
bacteria have become more common in health-care 
and community settings, and many bacteria have 
become resistant to multiple antibiotics. As resistance 
increases, so does a patient’s risk for dying from the 
infection (1).
Patients, health-care providers, hospital admin-
istrators, and policy makers must work together to 
apply effective strategies for improving antibiotic use 
to improve health, save lives, and reduce health-care 
expenditures. Information regarding appropriate use 
of antibiotics and about Get Smart About Antibiotics 
Week and how to participate is available at http://
www.cdc.gov/getsmart.
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QuickStats 
FROM THE NATIONAL CENTER FOR HEALTH STATISTICS
Delayed or Forgone Medical Care Because of Cost Concerns* Among Adults 
Aged 18–64 Years,† by Disability§ and Health Insurance Coverage Status¶ — 
National Health Interview Survey, United States, 2009 
 * Based on responses to two questions: “During the past 12 months, has [person] delayed seeking medical 
care because of worry about the cost?” and “During the past 12 months, was there any time when [person] 
needed medical care but did not get it because [person] could not afford it?” Both questions exclude dental 
care.
 † Estimates are age adjusted to the 2000 U.S. census civilian, noninstitutionalized population.
 § Disability is any difficulty in basic actions, which includes movement, vision, hearing, emotion, and cognition. 
Of 188,273,000 working age adults, 24.5% reported a difficulty in basic actions. 
 ¶ Insurance coverage includes public and private plans and is stratified by duration of coverage during the 
year before the interview.
 ** 95% confidence interval.
During 2009, working-age adults with a disability were approximately 2.5 times more likely than adults without a disability to 
report delaying or forgoing medical care in the past year because of cost. This difference was found for adults with and without 
health insurance coverage.  Among adults who were continuously insured for the past year, 15.5% of working-age adults with 
a disability reported delaying or forgoing medical care needs compared with 5.8% of those without a disability. For adults 
without coverage at any time during the past year or longer, the percentage of adults with a disability (60.8%) who reported 
delaying or forgoing medical care needs because of cost was twice as high as the percentage of adults without a disability 
(30.7%). Overall, delayed or forgone medical needs because of cost were highest among adults without insurance, regardless 
of disability status.
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TABLE I. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week ending 









Total cases reported 
for previous years States reporting cases 
during current week (No.)2009 2008 2007 2006 2005
Anthrax — — — 1 — 1 1 —
Botulism, total — 85 2 118 145 144 165 135
foodborne — 6 0 10 17 32 20 19
infant — 59 1 83 109 85 97 85
other (wound and unspecified) — 20 1 25 19 27 48 31
Brucellosis — 103 2 115 80 131 121 120
Chancroid 2 35 1 28 25 23 33 17 TN (2)
Cholera — 5 0 10 5 7 9 8
Cyclosporiasis§ 1 156 1 141 139 93 137 543 MA (1)
Diphtheria — — — — — — — —
Domestic arboviral diseases § ,¶:
California serogroup virus disease — 56 1 55 62 55 67 80
Eastern equine encephalitis virus disease — 10 — 4 4 4 8 21
Powassan virus disease — 5 0 6 2 7 1 1
St. Louis encephalitis virus disease — 7 0 12 13 9 10 13
Western equine encephalitis virus disease — — — — — — — —
Haemophilus influenzae,** invasive disease (age <5 yrs):
serotype b — 14 0 35 30 22 29 9
nonserotype b 2 131 3 236 244 199 175 135 WA (2)
unknown serotype 5 206 3 178 163 180 179 217 VT (1), NY (1), NYC (1), OH (1), FL (1)
Hansen disease§ 2 42 2 103 80 101 66 87 FL (1), CA (1)
Hantavirus pulmonary syndrome§ — 16 0 20 18 32 40 26
Hemolytic uremic syndrome, postdiarrheal§ 6 192 5 242 330 292 288 221 MD (1), AR (1), OK (4)
HIV infection, pediatric (age <13 yrs)†† — — 3 — — — — 380
Influenza-associated pediatric mortality§,§§ 1 58 5 358 90 77 43 45 TX (1)
Listeriosis 5 661 19 851 759 808 884 896 NY (1), OH (1), TN (1), OK (1), CO (1)
Measles¶¶ — 56 0 71 140 43 55 66
Meningococcal disease, invasive***:
A, C, Y, and W-135 1 198 5 301 330 325 318 297 WA (1)
serogroup B — 93 3 174 188 167 193 156
other serogroup — 7 1 23 38 35 32 27
unknown serogroup 5 324 9 482 616 550 651 765 PA (1), OH (1), FL (2), CA (1)
Mumps 4 2,447 19 1,991 454 800 6,584 314 NY (1), FL (1), CA (2)
Novel influenza A virus infections††† 1 2 0 43,774 2 4 NN NN PA (1)
Plague — 2 0 8 3 7 17 8
Poliomyelitis, paralytic — — — 1 — — — 1
Polio virus Infection, nonparalytic§ — — — — — — NN NN
Psittacosis§ — 4 0 9 8 12 21 16
Q fever, total§,§§§ — 100 3 114 120 171 169 136
acute — 76 1 94 106 — — —
chronic — 24 0 20 14 — — —
Rabies, human — 1 0 4 2 1 3 2
Rubella¶¶¶ — 6 0 3 16 12 11 11
Rubella, congenital syndrome — — — 2 — — 1 1
SARS-CoV§,**** — — — — — — — —
Smallpox§ — — — — — — — —
Streptococcal toxic-shock syndrome§ 4 142 1 161 157 132 125 129 CT (4)
Syphilis, congenital (age <1 yr)†††† — 168 8 423 431 430 349 329
Tetanus — 6 0 18 19 28 41 27
Toxic-shock syndrome (staphylococcal)§ 1 61 1 74 71 92 101 90 NY (1)
Trichinellosis — 3 0 13 39 5 15 16
Tularemia 2 95 1 93 123 137 95 154 MO (1), OK (1)
Typhoid fever 7 351 6 397 449 434 353 324 OH (1), FL (1), CA (5)
Vancomycin-intermediate Staphylococcus aureus§ 1 78 1 78 63 37 6 2 NY (1)
Vancomycin-resistant Staphylococcus aureus§ — 1 0 1 — 2 1 3
Vibriosis (noncholera Vibrio species infections)§ 4 674 9 789 588 549 NN NN VA (1), FL (2), AZ (1)
Viral hemorrhagic fever§§§§ — 1 — NN NN NN NN NN
Yellow fever — — — — — — — —
See Table I footnotes on next page.
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* No measles cases were reported for the current 4-week period yielding a ratio for week 44 of zero (0).
† Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the 
past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week 
totals.
FIGURE I. Selected notifiable disease reports, United States, comparison of provisional 4-week 



























TABLE I. (Continued) Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week 
ending November 6, 2010 (44th week)*
—: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts.
 * Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.
 † Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. 
Additional information is available at http://www.cdc.gov/ncphi/disss/nndss/phs/files/5yearweeklyaverage.pdf.
 § Not reportable in all states. Data from states where the condition is not reportable are excluded from this table except starting in 2007 for the domestic arboviral diseases, STD data, TB 
data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV.  Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
 ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and 
Enteric Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
 ** Data for H. influenzae (all ages, all serotypes) are available in Table II.
 †† Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences 
the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is 
completed. Data for HIV/AIDS, when available, are displayed in Table IV, which appears quarterly.
 §§ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since October 3, 2010, one influenza-associated pediatric death occurred 
during the 2010–11 influenza season. Since August 30, 2009, a total of 282 influenza-associated pediatric deaths occurring during the 2009–10 influenza season have been reported. 
 ¶¶ No measles cases were reported for the current week.
 *** Data for meningococcal disease (all serogroups) are available in Table II.
 ††† CDC discontinued reporting of individual confirmed and probable cases of 2009 pandemic influenza A (H1N1) virus infections on July 24, 2009. During 2009, four cases of human 
infection with novel influenza A viruses, different from the 2009 pandemic influenza A (H1N1) strain, were reported to CDC. The two cases of novel influenza A virus infection reported 
to CDC during 2010 were identified as swine influenza A (H3N2) virus and are unrelated to the 2009 pandemic influenza A (H1N1) virus. Total case counts for 2009 were provided by the 
Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD).
 §§§ In 2009, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with 
respect to acute and chronic Q fever cases.
 ¶¶¶ No rubella cases were reported for the current week.
 **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases.
 †††† Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
 §§§§ There was one case of viral hemorrhagic fever reported during week 12. The one case report was confirmed as lassa fever. See Table II for dengue hemorrhagic fever.
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TABLE II. Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Reporting area
Chlamydia trachomatis infection Cryptosporidiosis
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 9,957 23,384 26,199 1,005,521 1,063,819 50 122 336 6,650 6,461
New England 423 765 1,396 33,454 33,821 3 7 74 409 412
Connecticut 313 216 736 8,730 9,852 — 0 68 68 38
Maine† — 50 69 1,996 2,048 — 1 7 71 45
Massachusetts — 401 652 16,701 15,900 2 3 8 143 159
New Hampshire 51 41 114 2,069 1,824 — 1 5 48 76
Rhode Island† 42 64 120 2,899 3,173 — 0 2 13 22
Vermont† 17 23 51 1,059 1,024 1 1 5 66 72
Mid. Atlantic 2,819 3,255 4,766 144,182 134,571 5 14 37 695 728
New Jersey — 479 691 20,979 20,753 — 0 1 — 47
New York (Upstate) 602 679 2,530 29,178 26,778 1 3 16 184 192
New York City 1,683 1,210 2,741 54,208 49,996 1 1 5 78 73
Pennsylvania 534 902 1,092 39,817 37,044 3 8 26 433 416
E.N. Central 645 3,475 4,127 145,750 170,607 8 29 122 1,802 1,517
Illinois — 798 1,225 29,826 52,300 — 3 21 245 141
Indiana — 349 796 15,739 19,237 — 3 10 140 250
Michigan 379 907 1,420 40,719 39,269 — 5 18 283 243
Ohio 134 969 1,085 41,325 41,805 5 7 24 412 337
Wisconsin 132 424 509 18,141 17,996 3 9 55 722 546
W.N. Central 133 1,342 1,565 56,341 60,675 3 23 83 1,201 980
Iowa 12 191 269 8,523 8,221 — 4 24 310 185
Kansas 19 185 235 7,911 9,165 — 2 9 118 93
Minnesota — 275 331 11,185 12,374 — 0 18 98 294
Missouri — 495 599 20,430 22,184 2 4 30 346 171
Nebraska† 85 97 237 4,287 4,628 1 3 26 216 105
North Dakota — 33 89 1,375 1,530 — 0 18 29 11
South Dakota 17 61 77 2,630 2,573 — 2 6 84 121
S. Atlantic 1,364 4,634 5,681 199,916 215,461 9 18 51 869 1,001
Delaware 69 85 220 3,750 4,041 — 0 2 7 8
District of Columbia — 96 177 4,099 5,828 — 0 1 2 6
Florida 560 1,461 1,732 63,552 63,127 8 7 19 330 399
Georgia — 541 1,229 21,845 34,576 — 5 31 250 307
Maryland† — 467 1,031 19,501 19,060 — 1 3 32 38
North Carolina — 765 1,562 34,310 35,619 — 1 12 69 102
South Carolina† — 523 788 22,994 23,214 — 1 8 80 54
Virginia† 663 596 902 26,637 26,837 1 2 8 83 72
West Virginia 72 71 112 3,228 3,159 — 0 3 16 15
E.S. Central 780 1,741 2,415 75,079 80,297 4 4 19 277 204
Alabama† 191 491 757 22,345 22,832 — 2 12 131 59
Kentucky 266 277 642 12,562 11,215 3 1 6 76 58
Mississippi — 384 780 15,872 20,518 — 0 3 19 17
Tennessee† 323 574 729 24,300 25,732 1 1 5 51 70
W.S. Central 861 2,954 4,578 131,654 139,411 2 8 39 379 496
Arkansas† 268 259 392 10,362 12,508 1 0 3 31 50
Louisiana 305 228 1,076 12,456 24,154 — 1 5 53 50
Oklahoma 288 257 1,374 13,015 12,327 1 1 8 76 109
Texas† — 2,184 3,194 95,821 90,422 — 5 30 219 287
Mountain 762 1,465 1,904 63,326 68,374 5 10 29 482 507
Arizona 265 498 713 21,092 22,288 — 1 3 32 31
Colorado 207 369 577 15,044 16,888 4 2 8 119 129
Idaho† 49 72 200 3,396 3,179 — 2 6 81 81
Montana† — 60 81 2,526 2,580 1 1 4 44 51
Nevada† — 171 337 7,842 8,644 — 0 6 31 23
New Mexico† 241 162 453 6,709 7,872 — 2 11 104 136
Utah — 120 176 5,132 5,244 — 1 5 57 36
Wyoming† — 37 79 1,585 1,679 — 0 2 14 20
Pacific 2,170 3,643 5,350 155,819 160,602 11 12 28 536 616
Alaska — 111 148 4,955 4,469 — 0 1 4 6
California 1,915 2,784 4,406 121,008 122,897 9 7 19 307 363
Hawaii — 112 158 4,705 5,232 — 0 0 — 1
Oregon — 208 468 9,175 9,536 1 3 13 154 168
Washington 255 384 497 15,976 18,468 1 1 8 71 78
Territories
American Samoa — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam — 6 31 259 311 — 0 0 — —
Puerto Rico 254 92 265 4,692 6,402 N 0 0 N N
U.S. Virgin Islands — 9 29 323 445 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Dengue Virus Infection
Reporting area
Dengue Fever† Dengue Hemorrhagic Fever§
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 5 30 373 NN — 0 1 4 NN
New England — 0 2 4 NN — 0 0 — NN
Connecticut — 0 0 — NN — 0 0 — NN
Maine¶ — 0 2 3 NN — 0 0 — NN
Massachusetts — 0 0 — NN — 0 0 — NN
New Hampshire — 0 0 — NN — 0 0 — NN
Rhode Island¶ — 0 0 — NN — 0 0 — NN
Vermont¶ — 0 1 1 NN — 0 0 — NN
Mid. Atlantic — 1 9 76 NN — 0 0 — NN
New Jersey — 0 0 — NN — 0 0 — NN
New York (Upstate) — 0 0 — NN — 0 0 — NN
New York City — 0 7 63 NN — 0 0 — NN
Pennsylvania — 0 2 13 NN — 0 0 — NN
E.N. Central — 0 5 38 NN — 0 1 1 NN
Illinois — 0 0 — NN — 0 0 — NN
Indiana — 0 2 10 NN — 0 0 — NN
Michigan — 0 2 9 NN — 0 0 — NN
Ohio — 0 2 14 NN — 0 0 — NN
Wisconsin — 0 2 5 NN — 0 1 1 NN
W.N. Central — 0 2 17 NN — 0 0 — NN
Iowa — 0 1 2 NN — 0 0 — NN
Kansas — 0 1 1 NN — 0 0 — NN
Minnesota — 0 2 13 NN — 0 0 — NN
Missouri — 0 0 — NN — 0 0 — NN
Nebraska¶ — 0 0 — NN — 0 0 — NN
North Dakota — 0 1 1 NN — 0 0 — NN
South Dakota — 0 0 — NN — 0 0 — NN
S. Atlantic — 2 16 190 NN — 0 1 2 NN
Delaware — 0 0 — NN — 0 0 — NN
District of Columbia — 0 0 — NN — 0 0 — NN
Florida — 1 14 157 NN — 0 1 2 NN
Georgia — 0 2 9 NN — 0 0 — NN
Maryland¶ — 0 0 — NN — 0 0 — NN
North Carolina — 0 1 4 NN — 0 0 — NN
South Carolina¶ — 0 3 9 NN — 0 0 — NN
Virginia¶ — 0 3 9 NN — 0 0 — NN
West Virginia — 0 1 2 NN — 0 0 — NN
E.S. Central — 0 2 5 NN — 0 0 — NN
Alabama¶ — 0 2 2 NN — 0 0 — NN
Kentucky — 0 1 1 NN — 0 0 — NN
Mississippi — 0 1 1 NN — 0 0 — NN
Tennessee¶ — 0 1 1 NN — 0 0 — NN
W.S. Central — 0 1 4 NN — 0 1 1 NN
Arkansas¶ — 0 0 — NN — 0 1 1 NN
Louisiana — 0 0 — NN — 0 0 — NN
Oklahoma — 0 1 4 NN — 0 0 — NN
Texas¶ — 0 0 — NN — 0 0 — NN
Mountain — 0 2 16 NN — 0 0 — NN
Arizona — 0 1 6 NN — 0 0 — NN
Colorado — 0 0 — NN — 0 0 — NN
Idaho¶ — 0 1 2 NN — 0 0 — NN
Montana¶ — 0 1 3 NN — 0 0 — NN
Nevada¶ — 0 1 4 NN — 0 0 — NN
New Mexico¶ — 0 1 1 NN — 0 0 — NN
Utah — 0 0 — NN — 0 0 — NN
Wyoming¶ — 0 0 — NN — 0 0 — NN
Pacific — 0 5 23 NN — 0 0 — NN
Alaska — 0 0 — NN — 0 0 — NN
California — 0 5 11 NN — 0 0 — NN
Hawaii — 0 0 — NN — 0 0 — NN
Oregon — 0 0 — NN — 0 0 — NN
Washington — 0 2 12 NN — 0 0 — NN
Territories
American Samoa — 0 0 — NN — 0 0 — NN
C.N.M.I. — — — — NN — — — — NN
Guam — 0 0 — NN — 0 0 — NN
Puerto Rico — 97 534 8,701 NN — 0 3 32 NN
U.S. Virgin Islands — 0 0 — NN — 0 0 — NN
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Dengue Fever includes cases that meet criteria for Dengue Fever with hemorrhage, other clinical, and unknown case classifications. 
§ DHF includes cases that meet criteria for dengue shock syndrome (DSS), a more severe form of DHF.
¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Ehrlichiosis/Anaplasmosis†
Reporting area
Ehrlichia chaffeensis Anaplasma phagocytophilum Undetermined
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 4 8 181 536 868 8 11 309 671 838 — 2 35 95 159
New England — 0 3 4 50 1 1 8 73 244 — 0 2 7 2
Connecticut — 0 0 — — — 0 5 18 17 — 0 2 5 —
Maine§ — 0 1 2 4 1 0 2 16 12 — 0 0 — —
Massachusetts — 0 0 — 9 — 0 2 — 90 — 0 0 — —
New Hampshire — 0 1 2 4 — 0 3 15 16 — 0 1 2 1
Rhode Island§ — 0 2 — 32 — 0 7 24 109 — 0 0 — 1
Vermont§ — 0 0 — 1 — 0 0 — — — 0 0 — —
Mid. Atlantic 2 1 15 47 178 7 2 17 180 288 — 0 2 4 44
New Jersey — 0 2 — 96 — 0 2 1 68 — 0 0 — —
New York (Upstate) 2 0 15 28 50 7 2 17 176 211 — 0 1 4 6
New York City — 0 3 18 10 — 0 1 3 8 — 0 0 — 1
Pennsylvania — 0 2 1 22 — 0 1 — 1 — 0 1 — 37
E.N. Central — 0 4 32 83 — 3 39 334 265 — 1 6 60 70
Illinois — 0 2 12 33 — 0 1 2 6 — 0 2 4 3
Indiana — 0 0 — — — 0 0 — — — 0 3 28 36
Michigan — 0 1 2 5 — 0 0 — — — 0 1 4 —
Ohio — 0 3 6 13 — 0 1 2 1 — 0 0 — 2
Wisconsin — 0 1 12 32 — 3 39 330 258 — 0 4 24 29
W.N. Central — 1 13 116 152 — 0 261 11 19 — 0 30 11 16
Iowa — 0 0 — — — 0 0 — — — 0 0 — —
Kansas — 0 1 6 6 — 0 0 — 1 — 0 0 — —
Minnesota — 0 6 — 2 — 0 261 — 13 — 0 30 — 3
Missouri — 1 13 108 142 — 0 3 11 4 — 0 3 11 13
Nebraska§ — 0 1 2 2 — 0 0 — 1 — 0 0 — —
North Dakota — 0 0 — — — 0 0 — — — 0 0 — —
South Dakota — 0 0 — — — 0 0 — — — 0 0 — —
S. Atlantic 1 4 19 233 242 — 1 7 53 16 — 0 1 6 2
Delaware — 0 3 17 21 — 0 1 4 2 — 0 0 — —
District of Columbia — 0 0 — — — 0 0 — — — 0 0 — —
Florida — 0 2 8 11 — 0 1 3 3 — 0 0 — —
Georgia — 0 4 19 18 — 0 1 1 1 — 0 1 1 —
Maryland§ — 0 3 22 38 — 0 2 13 3 — 0 1 2 —
North Carolina — 2 13 98 60 — 0 4 20 3 — 0 0 — —
South Carolina§ — 0 2 3 10 — 0 1 1 — — 0 0 — —
Virginia§ — 1 13 65 83 — 0 2 11 4 — 0 1 3 2
West Virginia 1 0 0 1 1 — 0 0 — — — 0 1 — —
E.S. Central 1 1 10 83 130 — 0 2 17 3 — 0 1 6 24
Alabama§ 1 0 3 11 8 — 0 2 7 1 — 0 0 — —
Kentucky — 0 2 14 10 — 0 0 — — — 0 0 — —
Mississippi — 0 1 3 6 — 0 1 1 — — 0 0 — —
Tennessee§ — 1 6 55 106 — 0 2 9 2 — 0 1 6 24
W.S. Central — 0 141 20 30 — 0 23 3 1 — 0 1 1 —
Arkansas§ — 0 34 2 4 — 0 6 — — — 0 0 — —
Louisiana — 0 1 1 — — 0 0 — — — 0 0 — —
Oklahoma — 0 105 14 24 — 0 16 2 1 — 0 0 — —
Texas§ — 0 2 3 2 — 0 1 1 — — 0 1 1 —
Mountain — 0 0 — — — 0 0 — — — 0 0 — 1
Arizona — 0 0 — — — 0 0 — — — 0 0 — 1
Colorado — 0 0 — — — 0 0 — — — 0 0 — —
Idaho§ — 0 0 — — — 0 0 — — — 0 0 — —
Montana§ — 0 0 — — — 0 0 — — — 0 0 — —
Nevada§ — 0 0 — — — 0 0 — — — 0 0 — —
New Mexico§ — 0 0 — — — 0 0 — — — 0 0 — —
Utah — 0 0 — — — 0 0 — — — 0 0 — —
Wyoming§ — 0 0 — — — 0 0 — — — 0 0 — —
Pacific — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Alaska — 0 0 — — — 0 0 — — — 0 0 — —
California — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Hawaii — 0 0 — — — 0 0 — — — 0 0 — —
Oregon — 0 0 — — — 0 0 — — — 0 0 — —
Washington — 0 0 — — — 0 0 — — — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Cumulative total E. ewingii cases reported for year 2010 = 10.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Reporting area
Giardiasis Gonorrhea
Haemophilus influenzae, invasive†  
All ages, all serotypes
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 221 347 666 15,153 16,221 2,076 5,440 6,341 235,153 259,060 22 59 171 2,405 2,412
New England 19 32 54 1,387 1,521 52 105 196 4,469 4,167 5 3 21 151 166
Connecticut — 5 13 236 254 46 42 169 1,944 2,012 4 0 15 34 47
Maine§ 9 4 12 196 189 — 3 11 136 115 — 0 2 11 18
Massachusetts 9 13 24 600 653 — 46 81 1,952 1,623 — 2 8 77 77
New Hampshire — 3 8 128 180 5 3 7 134 91 — 0 2 10 11
Rhode Island§ — 1 7 60 54 1 5 14 256 288 — 0 2 11 8
Vermont§ 1 4 10 167 191 — 0 17 47 38 1 0 1 8 5
Mid. Atlantic 43 59 103 2,599 2,974 593 682 1,128 30,516 27,039 3 11 34 465 492
New Jersey — 5 13 207 377 — 102 161 4,563 4,065 — 2 7 75 108
New York (Upstate) 35 22 84 989 1,134 138 103 422 4,846 5,002 2 3 20 127 127
New York City 3 16 33 758 720 318 229 547 10,508 9,390 1 2 6 91 61
Pennsylvania 5 14 25 645 743 137 239 364 10,599 8,582 — 4 9 172 196
E.N. Central 18 53 80 2,438 2,526 148 923 1,260 39,928 54,536 2 10 20 407 381
Illinois — 12 26 492 538 — 182 380 7,025 17,354 — 3 9 123 143
Indiana — 5 13 197 258 — 96 221 4,437 6,182 — 1 6 71 68
Michigan — 13 23 578 577 58 245 471 11,164 12,807 — 0 4 27 19
Ohio 17 16 29 736 703 45 318 372 13,284 13,714 2 2 6 101 87
Wisconsin 1 8 30 435 450 45 94 155 4,018 4,479 — 2 5 85 64
W.N. Central 14 24 165 1,231 1,466 27 276 357 11,445 12,781 1 3 24 137 139
Iowa 3 5 11 253 258 6 33 53 1,452 1,424 — 0 1 1 —
Kansas — 4 10 183 136 1 37 83 1,587 2,172 — 0 2 13 13
Minnesota — 0 135 136 343 — 38 62 1,596 2,005 — 0 17 25 48
Missouri 5 8 25 371 456 — 124 172 5,356 5,584 — 1 6 68 51
Nebraska§ 6 3 9 188 155 20 22 50 1,005 1,186 1 0 2 20 21
North Dakota — 0 7 27 20 — 2 11 94 114 — 0 4 10 6
South Dakota — 1 7 73 98 — 7 18 355 296 — 0 0 — —
S. Atlantic 49 72 143 3,193 3,175 338 1,340 1,684 58,097 64,568 4 14 27 635 658
Delaware — 0 5 28 22 12 18 48 852 825 — 0 1 5 3
District of Columbia — 1 5 31 66 — 37 65 1,545 2,287 — 0 1 3 4
Florida 41 40 87 1,847 1,656 177 386 493 17,136 18,174 2 3 9 157 195
Georgia — 10 51 485 642 — 181 421 7,467 11,846 — 3 9 143 130
Maryland§ 3 5 11 224 245 — 133 237 5,676 5,211 2 1 6 57 77
North Carolina N 0 0 N N — 246 596 11,490 12,126 — 2 9 107 81
South Carolina§ — 2 9 123 95 — 155 232 6,917 7,295 — 2 7 69 65
Virginia§ 5 9 36 416 407 128 160 271 6,548 6,375 — 2 4 72 77
West Virginia — 0 6 39 42 21 9 20 466 429 — 0 5 22 26
E.S. Central — 5 15 220 361 211 478 698 20,385 23,117 1 3 12 146 140
Alabama§ — 4 10 163 171 57 145 218 6,461 6,561 — 0 3 22 35
Kentucky N 0 0 N N 75 75 156 3,284 3,268 — 0 2 30 19
Mississippi N 0 0 N N — 111 216 4,512 6,390 — 0 2 11 7
Tennessee§ — 1 10 57 190 79 145 195 6,128 6,898 1 2 10 83 79
W.S. Central 5 8 16 329 452 280 782 1,281 35,657 40,810 1 2 20 109 105
Arkansas§ 5 2 9 119 136 89 76 133 3,174 3,876 — 0 3 14 18
Louisiana — 3 9 147 177 98 68 441 3,576 7,865 — 0 3 21 18
Oklahoma — 2 7 63 139 93 75 359 3,825 3,907 1 1 15 66 65
Texas§ N 0 0 N N — 570 964 25,082 25,162 — 0 2 8 4
Mountain 17 30 49 1,377 1,447 78 179 262 7,502 7,981 2 5 15 246 207
Arizona 1 3 8 133 180 32 63 109 2,487 2,684 1 2 10 93 65
Colorado 13 13 27 582 421 22 52 95 2,274 2,405 — 1 5 67 62
Idaho§ 1 4 9 181 181 2 2 6 100 89 1 0 2 16 3
Montana§ 1 2 7 90 121 — 2 6 87 71 — 0 1 2 1
Nevada§ 1 1 11 88 99 — 29 94 1,380 1,479 — 0 2 7 16
New Mexico§ — 2 5 80 109 22 19 41 885 914 — 1 5 35 28
Utah — 4 11 189 277 — 6 15 261 278 — 0 4 20 29
Wyoming§ — 1 5 34 59 — 0 4 28 61 — 0 2 6 3
Pacific 56 53 133 2,379 2,299 349 601 809 27,154 24,061 3 2 21 109 124
Alaska — 2 6 85 101 — 23 37 1,054 836 — 0 2 20 17
California 32 33 61 1,482 1,482 311 494 691 22,512 19,789 1 0 18 19 40
Hawaii — 0 3 24 19 — 14 25 604 557 — 0 2 7 28
Oregon 6 9 20 416 353 — 19 43 830 931 — 1 5 57 36
Washington 18 8 75 372 344 38 50 69 2,154 1,948 2 0 4 6 3
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 2 3 — 0 4 30 19 — 0 0 — —
Puerto Rico — 1 8 58 142 12 5 14 257 208 — 0 1 1 4
U.S. Virgin Islands — 0 0 — — — 2 7 78 109 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Data for H. influenzae (age <5 yrs for serotype b, nonserotype b, and unknown serotype) are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*

















Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 21 30 69 1,287 1,704 28 62 204 2,604 2,805 5 14 44 675 639
New England 2 2 5 85 97 — 1 5 47 48 — 1 4 36 58
Connecticut 2 0 3 27 18 — 0 2 18 14 — 0 4 25 45
Maine† — 0 1 7 1 — 0 2 13 13 — 0 0 — 2
Massachusetts — 1 5 41 61 — 0 2 8 17 — 0 1 10 10
New Hampshire — 0 1 2 7 — 0 2 6 4 N 0 0 N N
Rhode Island† — 0 4 8 8 U 0 0 U U U 0 0 U U
Vermont† — 0 0 — 2 — 0 1 2 — — 0 1 1 1
Mid. Atlantic 1 4 10 173 240 — 5 10 240 291 — 2 6 96 89
New Jersey — 0 3 12 60 — 1 5 57 87 — 0 2 21 6
New York (Upstate) — 1 4 53 43 — 1 6 42 47 — 1 4 49 41
New York City — 1 5 62 76 — 2 4 75 61 — 0 0 — 5
Pennsylvania 1 1 4 46 61 — 1 5 66 96 — 0 3 26 37
E.N. Central — 4 8 182 261 1 9 17 386 379 — 2 8 96 77
Illinois — 1 3 40 118 — 1 5 71 105 — 0 1 1 4
Indiana — 0 2 15 16 — 1 5 47 64 — 0 2 21 18
Michigan — 1 4 60 63 — 3 6 104 112 — 1 4 58 28
Ohio — 0 5 42 35 1 2 6 81 77 — 0 1 8 24
Wisconsin — 0 3 25 29 — 1 8 83 21 — 0 2 8 3
W.N. Central 1 1 13 67 102 — 2 15 100 120 — 0 11 15 21
Iowa — 0 3 8 32 — 0 2 12 29 — 0 1 — 10
Kansas — 0 3 11 9 — 0 2 7 6 — 0 1 1 1
Minnesota — 0 12 14 18 — 0 13 7 23 — 0 9 6 6
Missouri 1 0 2 21 21 — 1 3 62 40 — 0 1 6 —
Nebraska† — 0 4 12 19 — 0 2 11 19 — 0 1 2 2
North Dakota — 0 1 — — — 0 0 — — — 0 1 — 1
South Dakota — 0 1 1 3 — 0 1 1 3 — 0 0 — 1
S. Atlantic 7 7 14 294 373 10 16 40 749 774 3 4 7 146 142
Delaware — 0 1 7 3 — 0 2 22 29 U 0 0 U U
District of Columbia — 0 1 1 1 — 0 1 3 10 — 0 1 2 1
Florida 7 3 7 120 157 8 5 11 255 248 3 1 5 49 38
Georgia — 1 3 34 44 — 2 7 127 131 — 0 2 7 30
Maryland† — 0 3 20 42 — 1 6 60 65 — 0 2 22 21
North Carolina — 1 5 45 35 — 1 16 85 96 — 0 3 36 20
South Carolina† — 0 3 22 55 — 1 4 51 49 — 0 1 1 1
Virginia† — 1 6 43 33 2 1 14 85 85 — 0 2 12 8
West Virginia — 0 2 2 3 — 0 14 61 61 — 0 5 17 23
E.S. Central — 1 3 33 35 3 8 13 306 291 — 3 8 126 89
Alabama† — 0 1 6 9 — 1 5 59 79 — 0 1 5 7
Kentucky — 0 2 13 8 1 2 8 108 70 — 2 5 87 53
Mississippi — 0 1 2 8 1 1 3 34 29 U 0 0 U U
Tennessee† — 0 2 12 10 1 2 8 105 113 — 1 4 34 29
W.S. Central 2 3 19 118 164 4 10 109 417 493 1 1 14 65 50
Arkansas† — 0 3 2 8 — 1 4 41 59 — 0 0 — 2
Louisiana — 0 2 8 6 — 1 4 40 61 — 0 1 7 7
Oklahoma — 0 3 1 3 2 2 19 81 86 1 0 12 28 12
Texas† 2 2 18 107 147 2 5 87 255 287 — 1 3 30 29
Mountain 1 3 8 122 141 1 2 8 100 116 1 1 5 42 44
Arizona — 1 5 57 60 — 0 2 27 39 U 0 0 U U
Colorado — 1 3 26 46 1 0 3 22 22 1 0 2 8 25
Idaho† — 0 2 6 4 — 0 1 6 11 — 0 2 9 4
Montana† — 0 1 4 6 — 0 1 1 1 — 0 0 — 1
Nevada† 1 0 2 14 11 — 0 3 33 28 — 0 1 4 3
New Mexico† — 0 1 4 7 — 0 1 5 6 — 0 2 11 6
Utah — 0 1 8 5 — 0 1 5 5 — 0 2 10 5
Wyoming† — 0 3 3 2 — 0 1 1 4 — 0 0 — —
Pacific 7 5 16 213 291 9 6 20 259 293 — 1 6 53 69
Alaska — 0 1 1 2 — 0 1 3 3 U 0 2 U U
California 6 4 15 176 232 8 4 17 180 205 — 0 4 21 37
Hawaii — 0 2 3 8 — 0 1 1 6 U 0 0 U U
Oregon — 0 2 16 14 — 1 4 34 39 — 0 3 14 16
Washington 1 0 2 17 35 1 1 4 41 40 — 0 6 18 14
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 6 18 4 — 1 6 40 50 — 0 7 35 42
Puerto Rico — 0 2 13 21 — 0 2 16 30 — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Reporting area
Legionellosis Lyme disease Malaria
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 24 59 113 2,715 3,025 127 406 2,336 23,856 33,629 14 27 89 1,230 1,203
New England 2 3 15 210 178 18 125 468 7,081 11,537 — 2 4 65 53
Connecticut 2 0 6 43 48 — 40 200 2,257 3,892 — 0 1 1 5
Maine† — 0 4 12 8 15 11 76 642 791 — 0 1 5 2
Massachusetts — 1 8 103 88 — 41 200 2,639 4,960 — 1 3 45 34
New Hampshire — 0 5 20 12 2 22 67 1,093 1,299 — 0 2 4 4
Rhode Island† — 0 4 23 15 — 1 40 146 223 — 0 1 7 5
Vermont† — 0 2 9 7 1 4 27 304 372 — 0 1 3 3
Mid. Atlantic 3 17 37 726 1,066 74 168 712 11,004 14,666 4 7 17 330 355
New Jersey — 2 9 78 195 — 43 202 2,818 4,728 — 0 4 1 91
New York (Upstate) 2 5 19 251 316 51 53 577 2,602 3,587 3 1 6 67 42
New York City — 2 10 121 212 — 2 17 67 969 — 4 14 213 175
Pennsylvania 1 6 17 276 343 23 75 379 5,517 5,382 1 1 3 49 47
E.N. Central 4 12 41 619 649 1 16 240 1,999 2,826 2 2 9 129 153
Illinois — 1 15 118 117 — 1 16 110 135 — 1 7 44 65
Indiana 1 2 6 96 56 — 1 7 66 80 — 0 2 8 20
Michigan 1 3 20 155 148 — 1 14 90 95 1 0 4 29 26
Ohio 2 4 15 204 257 — 0 5 21 49 1 0 5 38 33
Wisconsin — 0 11 46 71 1 12 215 1,712 2,467 — 0 1 10 9
W.N. Central — 2 19 103 107 — 2 1,395 113 220 — 1 11 62 61
Iowa — 0 2 13 21 — 0 10 78 106 — 0 2 11 10
Kansas — 0 2 10 7 — 0 1 6 18 — 0 2 10 7
Minnesota — 0 16 27 12 — 0 1,380 — 88 — 0 11 3 24
Missouri — 0 4 32 53 — 0 1 1 3 — 0 3 20 12
Nebraska† — 0 2 8 11 — 0 2 9 4 — 0 2 15 7
North Dakota — 0 1 6 1 — 0 15 18 — — 0 1 — —
South Dakota — 0 2 7 2 — 0 1 1 1 — 0 2 3 1
S. Atlantic 2 10 27 448 503 25 58 171 3,314 3,952 4 6 38 338 315
Delaware — 0 3 15 18 1 11 32 551 910 — 0 1 2 5
District of Columbia — 0 4 15 19 — 0 4 21 60 — 0 2 9 16
Florida 1 3 9 147 156 3 2 10 90 97 3 2 7 111 82
Georgia — 1 4 41 53 — 0 2 10 38 — 0 4 31 64
Maryland† — 2 8 98 133 9 25 99 1,453 1,848 — 1 18 74 61
North Carolina — 0 7 50 54 — 1 9 78 89 — 0 13 45 28
South Carolina† — 0 2 10 9 — 0 3 27 35 — 0 1 4 4
Virginia† 1 1 6 61 53 11 16 79 971 722 1 1 5 59 53
West Virginia — 0 3 11 8 1 0 32 113 153 — 0 2 3 2
E.S. Central 1 2 10 114 127 — 1 4 40 35 1 0 3 27 30
Alabama† — 0 2 15 17 — 0 1 2 3 1 0 1 7 9
Kentucky — 0 4 26 46 — 0 1 4 1 — 0 3 6 9
Mississippi — 0 3 9 4 — 0 0 — — — 0 2 2 3
Tennessee† 1 1 6 64 60 — 1 4 34 31 — 0 2 12 9
W.S. Central 1 3 14 124 107 1 2 44 90 194 — 2 31 75 57
Arkansas† — 0 2 13 7 — 0 0 — — — 0 1 2 5
Louisiana — 0 3 8 13 — 0 1 2 — — 0 1 4 5
Oklahoma 1 0 4 13 6 — 0 2 — — — 0 1 5 1
Texas† — 2 10 90 81 1 2 42 88 194 — 1 30 64 46
Mountain 3 3 10 146 123 — 0 3 21 53 — 1 4 54 45
Arizona 2 1 7 57 38 — 0 1 2 6 — 0 2 22 8
Colorado — 1 5 31 24 — 0 1 2 1 — 0 3 18 26
Idaho† 1 0 1 6 5 — 0 2 6 15 — 0 1 3 2
Montana† — 0 1 4 6 — 0 1 3 3 — 0 1 2 5
Nevada† — 0 2 19 12 — 0 1 1 12 — 0 1 5 —
New Mexico† — 0 2 7 9 — 0 2 5 5 — 0 1 1 —
Utah — 0 3 17 25 — 0 1 2 9 — 0 1 3 4
Wyoming† — 0 2 5 4 — 0 1 — 2 — 0 0 — —
Pacific 8 5 19 225 165 8 4 11 194 146 3 3 19 150 134
Alaska — 0 2 2 1 — 0 1 6 6 — 0 1 3 2
California 4 4 19 188 124 6 3 9 128 94 3 2 13 103 99
Hawaii — 0 1 1 1 N 0 0 N N — 0 1 1 1
Oregon — 0 3 12 16 1 1 4 47 36 — 0 3 12 11
Washington 4 0 4 22 23 1 0 3 13 10 — 0 5 31 21
Territories
American Samoa — 0 0 — — N 0 0 N N — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 1 — — 0 0 — — — 0 0 — —
Puerto Rico — 0 1 — 2 N 0 0 N N — 0 2 4 5
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Reporting area
Meningococcal disease, invasive† 
All groups Pertussis Rabies, animal
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 6 15 43 622 796 225 309 1,756 16,192 13,214 23 66 140 2,857 4,562
New England — 0 3 16 29 1 8 22 410 569 3 4 15 208 300
Connecticut — 0 2 2 3 — 1 8 95 46 — 0 14 59 132
Maine§ — 0 1 3 4 — 0 5 39 77 1 1 4 56 49
Massachusetts — 0 2 6 14 1 5 13 224 323 — 0 0 — —
New Hampshire — 0 0 — 3 — 0 2 15 72 1 0 5 13 29
Rhode Island§ — 0 0 — 4 — 0 9 26 40 — 1 4 31 38
Vermont§ — 0 1 5 1 — 0 4 11 11 1 1 5 49 52
Mid. Atlantic 1 1 4 53 89 32 25 64 1,274 1,023 11 18 41 880 512
New Jersey — 0 2 9 16 — 3 8 103 213 — 0 0 — —
New York (Upstate) — 0 3 11 17 14 8 27 457 188 11 9 19 450 394
New York City — 0 2 14 16 2 0 9 75 83 — 2 12 120 18
Pennsylvania 1 0 2 19 40 16 10 40 639 539 — 5 24 310 100
E.N. Central 1 2 8 110 144 77 77 173 4,011 2,754 — 2 27 218 215
Illinois — 0 4 19 37 — 12 29 615 565 — 1 11 112 81
Indiana — 0 3 23 32 — 9 26 468 326 — 0 0 — 25
Michigan — 0 2 18 19 6 23 53 1,131 749 — 1 5 63 63
Ohio 1 1 2 29 35 71 25 69 1,416 959 — 0 12 43 46
Wisconsin — 0 2 21 21 — 6 19 381 155 — 0 0 — —
W.N. Central — 1 6 42 68 22 30 627 1,882 1,928 1 4 16 211 350
Iowa — 0 3 9 10 — 9 26 427 207 — 0 2 7 31
Kansas — 0 2 6 13 — 3 9 136 217 — 1 4 56 69
Minnesota — 0 2 2 11 — 0 601 692 419 — 0 9 26 56
Missouri — 0 3 18 21 17 8 33 371 897 — 1 6 64 64
Nebraska§ — 0 2 5 8 5 2 13 189 130 1 1 4 45 77
North Dakota — 0 1 2 1 — 0 30 41 17 — 0 7 13 4
South Dakota — 0 1 — 4 — 1 5 26 41 — 0 2 — 49
S. Atlantic 2 3 7 116 143 6 27 78 1,304 1,438 8 21 73 946 1,889
Delaware — 0 1 2 2 — 0 4 11 13 — 0 0 — —
District of Columbia — 0 0 — — — 0 1 5 6 — 0 0 — —
Florida 2 1 5 53 45 3 5 28 272 466 — 0 60 72 161
Georgia — 0 2 9 29 — 3 18 202 209 — 0 13 — 357
Maryland§ — 0 1 7 10 1 3 8 115 130 4 7 14 325 352
North Carolina — 0 2 14 27 — 0 32 124 180 — 0 10 — 427
South Carolina§ — 0 1 10 11 — 5 19 294 228 — 0 0 — —
Virginia§ — 0 2 19 14 1 5 15 196 178 — 10 25 480 487
West Virginia — 0 2 2 5 1 1 13 85 28 4 1 7 69 105
E.S. Central — 1 4 38 26 5 14 33 644 701 — 3 7 133 133
Alabama§ — 0 2 6 7 — 4 8 169 271 — 0 4 45 —
Kentucky — 0 2 17 4 5 4 13 229 204 — 0 4 19 45
Mississippi — 0 1 5 3 — 1 7 58 62 — 0 1 1 4
Tennessee§ — 0 2 10 12 — 4 11 188 164 — 1 4 68 84
W.S. Central — 1 9 70 79 20 57 753 2,416 2,812 — 1 30 61 832
Arkansas§ — 0 1 5 8 — 3 29 159 311 — 0 7 21 38
Louisiana — 0 4 12 17 — 1 4 31 138 — 0 0 — —
Oklahoma — 0 7 15 12 1 0 41 55 41 — 0 30 40 32
Texas§ — 1 7 38 42 19 48 681 2,171 2,322 — 0 19 — 762
Mountain — 1 6 47 55 30 23 56 1,175 842 — 1 8 76 99
Arizona — 0 2 12 12 — 7 16 353 221 — 0 5 — —
Colorado — 0 4 15 18 30 4 16 228 197 — 0 0 — —
Idaho§ — 0 2 7 7 — 3 19 174 69 — 0 2 11 8
Montana§ — 0 1 1 5 — 1 12 67 53 — 0 3 16 25
Nevada§ — 0 1 8 4 — 0 7 30 24 — 0 2 7 6
New Mexico§ — 0 1 3 3 — 2 11 114 62 — 0 2 11 25
Utah — 0 1 1 2 — 4 14 199 194 — 0 2 10 12
Wyoming§ — 0 1 — 4 — 0 2 10 22 — 0 4 21 23
Pacific 2 3 16 130 163 32 40 207 3,076 1,147 — 3 12 124 232
Alaska — 0 1 1 6 — 0 6 37 44 — 0 2 12 11
California 1 2 13 85 104 6 27 179 2,335 582 — 2 12 100 210
Hawaii — 0 1 1 5 — 0 6 39 37 — 0 0 — —
Oregon — 1 2 27 35 1 6 16 292 238 — 0 2 12 11
Washington 1 0 7 16 13 25 5 38 373 246 — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 2 — — — 0 0 — —
Puerto Rico — 0 1 — — — 0 1 2 1 — 1 3 38 39
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Data for meningococcal disease, invasive caused by serogroups A, C, Y, and W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Reporting area
Salmonellosis Shiga toxin-producing E. coli (STEC)† Shigellosis
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 527 901 1,694 43,062 41,776 63 82 205 4,002 3,988 104 275 527 11,534 13,441
New England 6 31 444 2,021 1,972 1 3 52 179 237 — 4 62 287 314
Connecticut — 0 428 428 430 — 0 52 52 67 — 0 57 57 43
Maine§ 1 2 7 113 113 — 0 3 17 17 — 0 1 5 5
Massachusetts 5 23 54 1,126 1,002 1 2 8 74 92 — 4 16 201 217
New Hampshire — 3 10 148 239 — 0 2 18 35 — 0 2 12 21
Rhode Island§ — 2 17 140 129 — 0 26 2 1 — 0 3 11 23
Vermont§ — 1 5 66 59 — 0 2 16 25 — 0 1 1 5
Mid. Atlantic 35 89 218 4,945 4,837 5 9 31 447 384 7 33 53 1,352 2,506
New Jersey — 18 56 890 997 — 1 5 54 94 — 6 16 257 543
New York (Upstate) 20 25 78 1,268 1,141 5 3 15 177 132 3 4 19 205 185
New York City 2 25 56 1,186 1,118 — 1 7 65 54 — 6 14 260 406
Pennsylvania 13 28 82 1,601 1,581 — 3 13 151 104 4 15 35 630 1,372
E.N. Central 17 83 238 4,509 4,565 3 10 39 652 653 7 26 238 1,478 2,274
Illinois — 28 114 1,579 1,298 — 2 8 105 156 — 9 228 725 535
Indiana — 9 54 379 540 — 1 9 66 83 — 1 5 33 63
Michigan 2 15 48 800 862 — 2 16 147 125 2 5 9 210 204
Ohio 15 24 47 1,175 1,263 3 2 11 127 119 5 6 23 270 1,006
Wisconsin — 11 44 576 602 — 3 17 207 170 — 4 21 240 466
W.N. Central 11 47 98 2,154 2,318 8 11 39 586 661 10 48 88 1,867 919
Iowa 1 9 34 471 362 — 3 16 153 145 1 1 5 48 49
Kansas — 8 18 388 347 — 1 6 62 51 — 5 14 226 178
Minnesota — 0 32 178 486 — 0 13 31 191 — 0 4 14 69
Missouri 5 13 44 724 572 4 3 27 222 123 7 42 75 1,518 588
Nebraska§ 5 4 13 220 312 4 1 6 69 80 2 1 10 54 27
North Dakota — 0 39 47 59 — 0 10 17 7 — 0 5 — 4
South Dakota — 3 8 126 180 — 1 4 32 64 — 0 2 7 4
S. Atlantic 221 268 596 12,892 12,078 11 13 30 605 590 27 43 97 2,145 2,075
Delaware 2 3 11 161 126 — 0 2 6 12 — 1 10 39 116
District of Columbia — 1 6 64 87 — 0 1 5 2 — 0 4 22 22
Florida 194 127 227 5,412 5,404 3 4 13 209 149 25 14 53 946 397
Georgia — 39 129 2,268 2,103 — 1 15 92 65 — 13 39 647 570
Maryland§ 14 16 52 890 686 8 1 6 85 84 1 3 8 114 341
North Carolina — 29 197 1,637 1,612 — 1 10 63 99 — 2 18 168 341
South Carolina§ — 20 93 1,345 941 — 0 3 19 27 — 1 5 60 108
Virginia§ 11 18 68 968 926 — 2 15 110 126 1 2 15 123 172
West Virginia — 2 16 147 193 — 0 4 16 26 — 0 11 26 8
E.S. Central 40 52 177 3,381 2,740 6 4 11 218 191 4 12 40 611 718
Alabama§ 16 15 49 855 799 1 1 4 42 42 — 3 10 148 139
Kentucky 7 9 31 499 405 — 1 6 59 64 — 4 28 202 193
Mississippi 4 17 67 1,087 831 — 0 2 15 6 — 1 4 43 43
Tennessee§ 13 14 53 940 705 5 2 7 102 79 4 5 13 218 343
W.S. Central 50 115 547 5,267 5,098 7 5 68 260 267 12 51 251 2,118 2,514
Arkansas§ 15 10 43 707 555 1 1 5 45 37 1 1 9 61 277
Louisiana — 20 48 1,044 1,051 — 0 1 15 22 — 4 13 216 163
Oklahoma 14 11 46 577 549 6 0 27 31 30 1 6 96 237 250
Texas§ 21 74 477 2,939 2,943 — 3 41 169 178 10 36 144 1,604 1,824
Mountain 15 48 105 2,355 2,663 6 9 33 502 514 2 15 32 686 1,033
Arizona 2 18 42 829 921 4 1 9 70 57 2 8 19 372 744
Colorado 13 10 23 488 553 1 2 18 156 156 — 2 6 100 88
Idaho§ — 3 9 139 156 1 1 7 89 85 — 0 3 23 8
Montana§ — 2 7 77 101 — 1 5 37 33 — 0 1 6 11
Nevada§ — 4 22 258 225 — 0 5 28 33 — 1 6 43 65
New Mexico§ — 6 15 269 332 — 1 5 35 33 — 2 9 105 95
Utah — 5 17 257 286 — 1 7 73 104 — 0 4 37 18
Wyoming§ — 1 9 38 89 — 0 2 14 13 — 0 2 — 4
Pacific 132 113 299 5,538 5,505 16 10 46 553 491 35 20 64 990 1,088
Alaska — 1 5 74 62 — 0 1 2 1 — 0 2 1 2
California 94 84 227 4,194 4,097 9 5 35 246 230 31 16 51 820 874
Hawaii — 4 14 177 293 — 0 4 18 9 — 0 3 17 38
Oregon 1 8 48 453 392 1 2 8 97 73 1 1 4 53 45
Washington 37 15 61 640 661 6 3 19 190 178 3 2 20 99 129
Territories
American Samoa — 0 1 2 — — 0 0 — — — 1 1 4 3
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 2 7 11 — 0 0 — — — 0 3 1 10
Puerto Rico — 10 39 437 484 — 0 0 — — — 0 1 4 12
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*











Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 2 13 144 139 1 17 421 1,332 1,198
New England — 0 0 — 2 — 0 1 3 10
Connecticut — 0 0 — — — 0 0 — —
Maine§ — 0 0 — — — 0 1 2 5
Massachusetts — 0 0 — 1 — 0 1 — 5
New Hampshire — 0 0 — — — 0 1 1 —
Rhode Island§ — 0 0 — — — 0 0 — —
Vermont§ — 0 0 — 1 — 0 0 — —
Mid. Atlantic — 0 2 16 12 1 1 4 54 90
New Jersey — 0 0 — 2 — 0 2 — 58
New York (Upstate) — 0 1 2 — 1 0 3 17 13
New York City — 0 1 1 1 — 0 4 25 6
Pennsylvania — 0 2 13 9 — 0 1 12 13
E.N. Central — 0 2 6 9 — 1 9 85 79
Illinois — 0 1 4 1 — 0 5 27 47
Indiana — 0 1 2 3 — 0 5 43 10
Michigan — 0 0 — 4 — 0 1 1 1
Ohio — 0 0 — — — 0 2 13 17
Wisconsin — 0 0 — 1 — 0 1 1 4
W.N. Central — 0 4 17 18 — 4 21 292 249
Iowa — 0 0 — 1 — 0 1 4 4
Kansas — 0 1 2 1 — 0 0 — —
Minnesota — 0 1 — 1 — 0 1 — 1
Missouri — 0 4 13 7 — 4 20 284 240
Nebraska§ — 0 1 2 8 — 0 1 3 4
North Dakota — 0 0 — — — 0 1 1 —
South Dakota — 0 0 — — — 0 0 — —
S. Atlantic — 1 9 69 64 — 7 60 451 362
Delaware — 0 1 1 — — 0 3 19 17
District of Columbia — 0 0 — — — 0 1 — —
Florida — 0 1 3 — — 0 2 11 6
Georgia — 0 6 47 50 — 0 0 — —
Maryland§ — 0 1 2 3 — 1 4 49 35
North Carolina — 0 3 11 7 — 1 48 235 238
South Carolina§ — 0 1 1 3 — 0 2 16 15
Virginia§ — 0 2 4 1 — 1 12 121 49
West Virginia — 0 0 — — — 0 0 — 2
E.S. Central — 0 4 20 9 — 4 29 355 251
Alabama§ — 0 1 5 3 — 1 8 71 61
Kentucky — 0 2 6 1 — 0 0 — —
Mississippi — 0 0 — — — 0 2 10 9
Tennessee§ — 0 3 9 5 — 3 20 274 181
W.S. Central — 0 3 6 9 — 1 408 80 133
Arkansas§ — 0 2 2 — — 0 110 37 67
Louisiana — 0 0 — — — 0 1 2 2
Oklahoma — 0 3 3 7 — 0 287 22 45
Texas§ — 0 1 1 2 — 0 11 19 19
Mountain — 0 1 2 15 — 0 2 12 24
Arizona — 0 1 — 9 — 0 1 2 12
Colorado — 0 0 — 1 — 0 1 1 —
Idaho§ — 0 0 — — — 0 1 5 1
Montana§ — 0 1 2 4 — 0 1 1 6
Nevada§ — 0 0 — — — 0 0 — 1
New Mexico§ — 0 0 — — — 0 1 1 1
Utah — 0 0 — — — 0 1 1 1
Wyoming§ — 0 0 — 1 — 0 1 1 2
Pacific — 0 2 8 1 — 0 0 — —
Alaska N 0 0 N N N 0 0 N N
California — 0 2 7 1 — 0 0 — —
Hawaii N 0 0 N N N 0 0 N N
Oregon — 0 1 1 — — 0 0 — —
Washington — 0 0 — — — 0 0 — —
Territories
American Samoa N 0 0 N N N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam N 0 0 N N N 0 0 N N
Puerto Rico N 0 0 N N N 0 0 N N
U.S. Virgin Islands — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses. Rocky Mountain spotted fever (RMSF) caused 
by Rickettsia rickettsii, is the most common and well-known spotted fever.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
Streptococcus pneumoniae,† invasive disease
Reporting area
All ages Age <5 Syphilis, primary and secondary
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 159 214 495 11,801 2,484 27 49 156 1,821 1,988 67 244 413 10,351 11,947
New England 18 9 99 644 46 4 1 24 84 65 3 9 22 387 271
Connecticut 13 0 91 288 — 3 0 22 27 — 1 1 10 81 49
Maine§ 2 2 6 104 16 — 0 1 8 7 — 0 3 23 2
Massachusetts — 1 5 58 3 — 1 4 39 40 — 5 15 229 195
New Hampshire — 0 7 59 — — 0 1 3 11 2 0 2 21 13
Rhode Island§ — 0 35 68 15 — 0 2 2 3 — 1 4 31 12
Vermont§ 3 1 6 67 12 1 0 1 5 4 — 0 2 2 —
Mid. Atlantic 20 23 56 1,114 169 5 7 48 298 250 21 33 45 1,443 1,517
New Jersey — 1 8 86 — — 1 5 45 50 — 4 12 196 195
New York (Upstate) 5 3 12 135 68 4 2 19 97 111 3 2 11 113 99
New York City 7 8 28 481 14 — 1 24 108 74 18 18 31 824 927
Pennsylvania 8 8 22 412 87 1 1 5 48 15 — 7 16 310 296
E.N. Central 30 46 98 2,405 557 4 8 18 305 335 1 28 47 1,100 1,323
Illinois — 1 7 83 — — 2 5 76 58 — 8 23 352 643
Indiana — 7 24 450 211 — 1 6 39 70 — 3 14 147 135
Michigan 2 11 27 578 24 — 2 6 71 62 1 4 12 177 202
Ohio 25 18 49 994 322 4 2 6 86 107 — 9 18 387 303
Wisconsin 3 6 22 300 — — 1 4 33 38 — 1 3 37 40
W.N. Central 2 8 182 633 161 1 2 12 114 159 — 6 19 275 262
Iowa — 0 0 — — — 0 0 — — — 0 3 16 21
Kansas — 1 7 77 52 — 0 2 13 18 — 0 3 18 28
Minnesota — 0 179 287 39 — 0 10 44 73 — 2 9 107 61
Missouri 2 2 10 95 59 1 1 3 34 42 — 3 10 124 143
Nebraska§ — 2 7 108 2 — 0 2 13 11 — 0 1 6 5
North Dakota — 0 11 50 7 — 0 1 2 5 — 0 0 — 4
South Dakota — 0 3 16 2 — 0 2 8 10 — 0 1 4 —
S. Atlantic 27 49 144 2,706 1,120 4 12 28 451 477 18 57 218 2,534 2,862
Delaware 1 0 3 32 18 — 0 0 — 3 — 0 2 4 25
District of Columbia — 0 4 23 19 — 0 2 7 5 — 2 21 139 150
Florida 18 22 89 1,230 653 2 3 18 168 167 1 20 45 903 894
Georgia — 10 28 437 334 — 3 12 121 133 — 13 167 546 681
Maryland§ 6 7 31 422 4 1 1 6 46 67 — 6 13 258 261
North Carolina — 0 0 — — — 0 0 — — — 7 31 296 474
South Carolina§ — 6 25 413 — — 1 4 44 42 — 2 7 128 107
Virginia§ 1 0 4 48 — 1 1 4 46 41 17 4 22 255 266
West Virginia 1 2 21 101 92 — 0 4 19 19 — 0 2 5 4
E.S. Central 17 20 50 1,051 227 3 2 8 103 123 9 17 39 781 981
Alabama§ — 0 0 — — — 0 0 — — 3 5 11 212 380
Kentucky 3 3 16 160 64 — 0 2 13 8 6 2 13 117 55
Mississippi — 1 6 47 45 — 0 2 10 22 — 4 17 186 184
Tennessee§ 14 15 44 844 118 3 2 7 80 93 — 6 17 266 362
W.S. Central 31 24 91 1,530 102 4 5 41 241 297 5 38 62 1,574 2,419
Arkansas§ 6 3 9 145 47 1 0 3 15 37 3 3 13 150 231
Louisiana — 1 8 78 55 — 0 3 21 24 2 7 26 354 677
Oklahoma — 1 5 40 — — 1 5 40 52 — 2 7 72 80
Texas§ 25 20 83 1,267 — 3 3 34 165 184 — 25 34 998 1,431
Mountain 13 24 82 1,466 99 2 4 12 195 254 2 9 23 417 463
Arizona 5 10 51 665 — 2 1 7 84 107 — 3 7 124 206
Colorado 6 8 20 437 — — 1 4 55 41 — 2 8 112 84
Idaho§ — 0 2 12 — — 0 2 6 7 — 0 1 2 3
Montana§ — 0 2 18 — — 0 1 2 — — 0 1 2 2
Nevada§ 1 1 4 69 36 — 0 1 5 7 — 1 9 101 86
New Mexico§ 1 2 9 127 — — 0 4 15 32 2 1 4 42 53
Utah — 2 9 127 53 — 0 3 25 58 — 1 4 34 26
Wyoming§ — 0 1 11 10 — 0 1 3 2 — 0 0 — 3
Pacific 1 5 14 252 3 — 0 7 30 28 8 42 60 1,840 1,849
Alaska — 2 9 98 — — 0 5 18 19 — 0 1 1 —
California 1 3 12 154 — — 0 2 12 — 5 35 54 1,594 1,646
Hawaii — 0 0 — 3 — 0 1 — 9 — 0 3 27 33
Oregon — 0 0 — — — 0 0 — — — 1 6 52 44
Washington — 0 0 — — — 0 0 — — 3 3 10 166 126
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — 3 3 15 193 192
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Includes drug resistant and susceptible cases of invasive Streptococcus pneumoniae disease among children <5 years and among all ages. Case definition: Isolation of S. pneumoniae from 
a normally sterile body site (e.g., blood or cerebrospinal fluid).
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending November 6, 2010, and November 7, 2009 (44th week)*
West Nile virus disease†
Reporting area
Varicella (chickenpox)§ Neuroinvasive Nonneuroinvasive¶
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 184 301 547 12,036 17,941 — 0 69 566 384 — 1 52 365 334
New England 11 15 36 632 944 — 0 3 13 — — 0 1 2 —
Connecticut — 6 20 256 431 — 0 2 6 — — 0 1 1 —
Maine§ 4 4 15 195 205 — 0 0 — — — 0 0 — —
Massachusetts — 0 1 2 4 — 0 2 6 — — 0 1 1 —
New Hampshire — 2 8 114 182 — 0 1 1 — — 0 0 — —
Rhode Island§ 2 1 12 31 34 — 0 0 — — — 0 0 — —
Vermont§ 5 0 10 34 88 — 0 0 — — — 0 0 — —
Mid. Atlantic 34 30 62 1,350 1,803 — 0 19 123 9 — 0 13 62 1
New Jersey — 8 30 448 385 — 0 3 14 3 — 0 6 15 —
New York (Upstate) N 0 0 N N — 0 9 57 3 — 0 7 30 1
New York City — 0 0 — — — 0 7 32 3 — 0 4 8 —
Pennsylvania 34 21 39 902 1,418 — 0 3 20 — — 0 3 9 —
E.N. Central 62 101 176 4,025 5,620 — 0 14 67 9 — 0 6 28 4
Illinois — 23 49 1,007 1,383 — 0 10 35 5 — 0 4 15 —
Indiana§ — 6 35 355 392 — 0 1 4 2 — 0 2 6 2
Michigan 18 31 62 1,199 1,650 — 0 6 25 1 — 0 1 4 —
Ohio 44 29 56 1,165 1,680 — 0 1 3 — — 0 1 1 2
Wisconsin — 7 22 299 515 — 0 0 — 1 — 0 1 2 —
W.N. Central 7 15 40 678 1,121 — 0 7 28 26 — 0 11 68 75
Iowa N 0 0 N N — 0 1 2 — — 0 2 4 5
Kansas§ — 6 22 231 478 — 0 1 3 4 — 0 2 10 9
Minnesota — 0 0 — — — 0 1 4 1 — 0 3 4 3
Missouri 6 7 23 370 534 — 0 1 3 4 — 0 0 — 1
Nebraska§ N 0 0 N N — 0 3 10 11 — 0 7 27 41
North Dakota — 0 26 37 57 — 0 2 2 — — 0 2 7 1
South Dakota 1 0 6 40 52 — 0 2 4 6 — 0 3 16 15
S. Atlantic 24 35 98 1,826 2,305 — 0 4 32 16 — 0 4 19 2
Delaware§ — 0 3 19 11 — 0 0 — — — 0 0 — —
District of Columbia — 0 4 17 29 — 0 1 1 2 — 0 1 1 —
Florida§ 10 15 57 881 1,044 — 0 2 8 2 — 0 1 3 1
Georgia N 0 0 N N — 0 1 4 4 — 0 3 8 —
Maryland§ N 0 0 N N — 0 3 16 — — 0 2 7 1
North Carolina N 0 0 N N — 0 0 — — — 0 0 — —
South Carolina§ — 0 35 75 111 — 0 1 1 3 — 0 0 — —
Virginia§ 6 11 34 443 661 — 0 1 2 5 — 0 0 — —
West Virginia 8 8 26 391 449 — 0 0 — — — 0 0 — —
E.S. Central 1 6 22 258 491 — 0 1 8 36 — 0 3 9 27
Alabama§ 1 5 22 251 486 — 0 1 1 — — 0 1 2 —
Kentucky N 0 0 N N — 0 1 2 3 — 0 1 1 —
Mississippi — 0 2 7 5 — 0 1 3 29 — 0 2 4 22
Tennessee§ N 0 0 N N — 0 1 2 4 — 0 2 2 5
W.S. Central 36 46 285 2,354 4,367 — 0 15 90 117 — 0 3 15 35
Arkansas§ — 2 32 122 440 — 0 3 6 6 — 0 1 1 —
Louisiana — 1 5 40 119 — 0 3 14 10 — 0 1 6 11
Oklahoma N 0 0 N N — 0 0 — 8 — 0 0 — 2
Texas§ 36 41 272 2,192 3,808 — 0 15 70 93 — 0 2 8 22
Mountain 9 20 36 866 1,197 — 0 18 145 77 — 0 15 126 123
Arizona — 0 0 — — — 0 13 98 12 — 0 9 59 8
Colorado§ 6 8 18 354 464 — 0 5 26 36 — 0 11 55 67
Idaho§ N 0 0 N N — 0 0 — 9 — 0 1 1 29
Montana§ 3 3 17 174 143 — 0 0 — 2 — 0 0 — 3
Nevada§ N 0 0 N N — 0 0 — 7 — 0 1 2 5
New Mexico§ — 2 8 88 104 — 0 5 18 6 — 0 2 4 2
Utah — 5 17 237 486 — 0 1 1 1 — 0 1 1 1
Wyoming§ — 0 3 13 — — 0 1 2 4 — 0 1 4 8
Pacific — 1 5 47 93 — 0 7 60 94 — 0 5 36 67
Alaska — 0 5 36 55 — 0 0 — — — 0 0 — —
California — 0 0 — — — 0 7 60 67 — 0 5 36 45
Hawaii — 0 2 11 38 — 0 0 — — — 0 0 — —
Oregon N 0 0 N N — 0 0 — 1 — 0 0 — 10
Washington N 0 0 N N — 0 0 — 26 — 0 0 — 12
Territories
American Samoa N 0 0 N N — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 3 15 26 — 0 0 — — — 0 0 — —
Puerto Rico — 9 30 494 480 — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change.  For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.  Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for California 
serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
¶ Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenza-
associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
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TABLE III. Deaths in 122 U.S. cities,* week ending November 6, 2010 (44th week)
Reporting area
All causes, by age (years)
P&I† 
Total Reporting area




Ages ≥65 45–64 25–44 1–24 <1
All  
Ages ≥65 45–64 25–44 1–24 <1
New England 525 379 102 23 9 12 62 S. Atlantic 1,312 839 316 89 38 30 85
Boston, MA 135 83 43 4 2 3 19 Atlanta, GA 133 72 36 14 11 — 4
Bridgeport, CT 23 17 4 2 — — 1 Baltimore, MD 108 64 33 4 4 3 13
Cambridge, MA 6 5 1 — — — — Charlotte, NC 146 96 32 12 3 3 11
Fall River, MA 22 19 3 — — — 2 Jacksonville, FL 168 112 37 10 3 6 11
Hartford, CT 50 36 7 3 2 2 4 Miami, FL 186 116 54 9 3 4 14
Lowell, MA 24 21 2 1 — — 3 Norfolk, VA 48 30 12 3 2 1 3
Lynn, MA 8 7 — 1 — — — Richmond, VA 66 41 18 6 1 — 7
New Bedford, MA 26 22 2 1 1 — 3 Savannah, GA 60 40 11 6 — 3 5
New Haven, CT 52 31 13 1 2 5 6 St. Petersburg, FL 51 37 8 4 — 2 3
Providence, RI 50 37 10 1 — 2 2 Tampa, FL 241 162 53 17 7 2 9
Somerville, MA 2 1 — — 1 — — Washington, D.C. 95 62 20 4 3 6 3
Springfield, MA 35 26 6 2 1 — — Wilmington, DE 10 7 2 — 1 — 2
Waterbury, CT 23 18 4 1 — — 2 E.S. Central 847 539 216 49 22 21 51
Worcester, MA 69 56 7 6 — — 20 Birmingham, AL 186 108 51 15 6 6 16
Mid. Atlantic 2,001 1,373 451 98 40 38 108 Chattanooga, TN 72 45 17 5 3 2 2
Albany, NY 53 32 13 5 2 1 3 Knoxville, TN 94 64 24 5 — 1 1
Allentown, PA 13 11 1 — 1 — 2 Lexington, KY 80 54 18 6 2 — 2
Buffalo, NY 81 55 21 1 2 2 8 Memphis, TN 190 121 54 6 3 6 12
Camden, NJ 26 16 3 2 4 1 2 Mobile, AL 58 37 11 4 4 2 2
Elizabeth, NJ 22 17 5 — — — — Montgomery, AL 44 25 14 2 2 1 4
Erie, PA 53 44 8 1 — — 3 Nashville, TN 123 85 27 6 2 3 12
Jersey City, NJ 27 19 6 2 — — 3 W.S. Central 1,397 859 361 90 54 33 66
New York City, NY 1,034 729 230 47 17 10 48 Austin, TX 80 45 21 8 6 — 3
Newark, NJ 26 7 15 4 — — — Baton Rouge, LA 72 54 11 3 3 1 —
Paterson, NJ 19 9 8 — 1 1 4 Corpus Christi, TX 70 48 16 2 1 3 11
Philadelphia, PA 356 210 96 24 8 18 12 Dallas, TX 210 116 64 15 8 7 15
Pittsburgh, PA§ 27 20 7 — — — 3 El Paso, TX 120 82 24 6 5 3 3
Reading, PA 26 23 2 — — 1 1 Fort Worth, TX U U U U U U U
Rochester, NY 66 46 8 6 2 4 6 Houston, TX 388 206 125 35 13 9 17
Schenectady, NY 24 22 2 — — — — Little Rock, AR 64 47 11 4 1 1 —
Scranton, PA 20 15 4 1 — — — New Orleans, LA U U U U U U U
Syracuse, NY 77 59 15 2 1 — 12 San Antonio, TX 241 163 51 10 10 7 11
Trenton, NJ 19 14 2 1 2 — — Shreveport, LA 17 11 3 — 2 1 1
Utica, NY 20 16 3 1 — — 1 Tulsa, OK 135 87 35 7 5 1 5
Yonkers, NY 12 9 2 1 — — — Mountain 1,017 668 241 65 27 15 71
E.N. Central 1,902 1,291 456 97 35 23 129 Albuquerque, NM 117 78 34 3 2 — 9
Akron, OH 41 33 7 1 — — 6 Boise, ID 58 39 11 5 — 3 3
Canton, OH 40 28 11 — — 1 1 Colorado Springs, CO 62 37 18 5 2 — 5
Chicago, IL 209 132 59 14 4 — 25 Denver, CO 93 60 20 8 1 4 6
Cincinnati, OH 85 44 31 5 3 2 7 Las Vegas, NV 215 134 63 11 5 2 18
Cleveland, OH 263 188 63 6 4 2 15 Ogden, UT 29 21 3 3 1 1 3
Columbus, OH 203 138 41 17 2 5 15 Phoenix, AZ 163 92 44 16 8 3 10
Dayton, OH 129 80 37 9 2 1 12 Pueblo, CO 40 34 5 — 1 — —
Detroit, MI 145 87 41 14 2 1 7 Salt Lake City, UT 114 84 16 9 3 2 10
Evansville, IN 37 29 6 1 — 1 4 Tucson, AZ 126 89 27 5 4 — 7
Fort Wayne, IN 81 57 21 — 2 1 4 Pacific 1,481 1,047 314 60 26 34 119
Gary, IN 19 9 9 1 — — — Berkeley, CA 20 13 5 1 1 — 2
Grand Rapids, MI 38 28 7 2 1 — 2 Fresno, CA 123 83 27 9 — 4 10
Indianapolis, IN 145 97 27 9 4 8 13 Glendale, CA 45 40 5 — — — 11
Lansing, MI 64 50 10 2 1 1 2 Honolulu, HI 88 66 13 3 3 3 2
Milwaukee, WI 85 56 25 3 1 — 4 Long Beach, CA 69 50 15 1 2 1 6
Peoria, IL 57 37 11 6 3 — 5 Los Angeles, CA 235 154 55 12 8 6 30
Rockford, IL 45 36 6 1 2 — 2 Pasadena, CA 22 21 — — — 1 1
South Bend, IN 49 33 13 1 2 — 1 Portland, OR 109 70 31 5 2 1 9
Toledo, OH 106 76 24 5 1 — 2 Sacramento, CA 139 105 24 5 — 5 9
Youngstown, OH 61 53 7 — 1 — 2 San Diego, CA 29 16 5 1 — 7 3
W.N. Central 633 412 151 36 18 16 48 San Francisco, CA 104 69 27 4 1 3 9
Des Moines, IA 36 18 13 2 1 2 1 San Jose, CA 185 137 36 8 4 — 9
Duluth, MN 26 20 5 — 1 — 1 Santa Cruz, CA 30 24 4 1 1 — 1
Kansas City, KS 27 13 9 3 1 1 3 Seattle, WA 98 56 30 8 1 3 4
Kansas City, MO 101 57 34 7 2 1 9 Spokane, WA 63 43 16 2 2 — 7
Lincoln, NE 49 37 10 1 1 — 1 Tacoma, WA 122 100 21 — 1 — 6
Minneapolis, MN 50 29 15 3 2 1 7 Total¶ 11,115 7,407 2,608 607 269 222 739
Omaha, NE 88 60 21 4 — 3 10
St. Louis, MO 118 66 24 14 8 6 8
St. Paul, MN 62 48 11 — 1 2 5
Wichita, KS 76 64 9 2 1 — 3
U: Unavailable.   —: No reported cases.   
* Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and 
by the week that the death certificate was filed. Fetal deaths are not included.
† Pneumonia and influenza.
§ Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Complete counts will be available in 4 to 6 weeks.
¶ Total includes unknown ages.
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